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Abstract 
 
 Although the behavior of nanomedicines is well characterized, understanding of the 
difference between the synthetic and biological identity of nanoparticles (NPs) is limited. To 
expand our knowledge base, we probe the stability of NPs and protein corona formation in 
increasingly in vivo-like conditions. The protein corona consists of various proteins at different 
relative abundances, rapidly forming when NPs are exposed to protein-rich environments. We 
begin our investigation through the synthesis and conjugation of 11.2 nm, citrate-stabilized gold 
nanoparticles (AuNPs).  Coating AuNPs with low fouling polymers, such as poly(ethylene glycol) 
(PEG) or poly-EK (PEK), increases the biocompatibility, biodistribution, and physiological half-
life of AuNPs.  We evaluate the protein corona formation in the presence of two types of 
polymer coatings: methoxy-terminated PEG (MPEG) and PEK. Using UV-visible absorption 
spectroscopy, dynamic light scattering (DLS), and Zeta-potential, we first monitor size, charge, 
and monodispersity to confirm functionalization. Second, incubating each AuNP model with 
bovine serum albumin (BSA) and lysozyme under various conditions confirms that proteins 
adsorb to our models and that their adsorption changes the surface chemistry of the NPs. 
Finally, protein corona formation in complex media is evaluated by incubating the AuNPs 
models with increasingly concentrated pooled human serum. Through purification, digestion, 
and analysis via HPLC/MS-MS, UV-Vis, DLS, we determine the types and amount of protein 
that form the corona. In addition, by studying corona formation around MPEG- and PEK-
conjugated maleimide polystyrene magnetic beads, we isolate the role that the gold 
nanoparticle and stealth coating may each play. The stability of the AuNPs in human serum is 
also analyzed through ICP-OES.   This study aims to inform nanomedicine design and provide 
insight into biological identity of NPs. 
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“Science and everyday life cannot and should not be separated. Science, for me, gives a partial 
explanation for life. In so far as it goes, it is based on fact, experience and experiment.” 
 –Rosalind Franklin, 1940 
 
 
“There’s plenty of room at the bottom.” 
 –Richard P. Feynman, 1959 
 
 
“If we can reduce the cost and improve the quality of medical technology through advances in 
nanotechnology, we can more widely address the medical conditions that are prevalent and 
reduce the level of human suffering.” 
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I. Introduction  	
Many types of nanoparticles (NPs) are currently researched for diverse biomedical 
applications: cancer treatment, implantable biosensors, and biofilms.7-9 However, our 
understanding of NP behavior within complex media, like protein-enriched serum, is limited.10 In 
vitro behaviors may not translate when NPs are exposed to in vivo-like environments.11 
Experiments that expose NPs to cells in simple media, like water or lab solutions, may address 
how well cells can uptake NPs. However, these studies do not acknowledge that NPs may be 
compromised by nonspecific protein adsorption during transit.12-13 Some published studies have 
investigated the interaction between AuNPs and single proteins or even 10% human serum.1, 5-6, 
14 Yet, these model systems underestimate the impact of complex media on NP stability.6, 15-16 
As nanotechnology advances drug delivery, understanding how proteins adsorb to the NP’s 
surface is critical. Ultimately, the protein “corona” could adversely affect NP biodistribution and 
efficacy.17 Characterizing its formation can help inform predictions of nanomedicine behavior in 
vivo. 
Nanomedicines, which scale from 10–9 to 10–7 meters, capitalize on nanotechnology 
innovations in the medical field.11 On this nanoscale, scientists can leverage naturally occurring 
high surface area-to-volume ratios to influence biological, physical, and chemical properties of 
materials.18 The materials utilized (e.g., liposomes, metals, and polymers) determine the 
function of the nanomedicine with various advantages and disadvantages. For example, 
liposomes easily diffuse into membrane spaces, but are invisible diagnostically.19 In general, 
nanoparticles benefit from surface area-to volume ratios and enhanced retention in the cell. 
High surface area-to volume ratios allow nanoscientists to leverage the enhanced permeability 
and retention (EPR) effect through NPs that can extravasate through the leaky tumor 
vasculature.20 The leakiness of the vasculature is due to the chaotic angiogenesis of tumor 
cells, leaving gaps wide enough for the NPs to permeate into the tumor architecture.21 Although 
Polymer/SPIO composites are most commonly used for NP-based diagnostics, AuNPs, which is 
	 Cheema 8 
the focus of this research, are increasingly used for their advantages in surface-to-volume ratios 
and low toxicity.22,23 Gold exhibits remarkable size-dependent electro-optical and catalytic 
properties on the nanoscale.24,25 AuNPs smaller than 50 nm in diameter have unique surface 
plasmon resonance. The mean-free path of surface electrons exceeds the size of the particle. 
This implies that AuNPs can absorb exceptional amounts energy when irradiated with light at 
the appropriate wavelength.26,27 Further, simple surface modification on AuNPs allows for the 
attachment of thiolyated polymers or moieties. These attachments range in possibility: 
stabilizing, targeting, and treatment molecules.5,28,29 Given various advantages in small size and 
biocompatibility, nanoscientists have leveraged NPs to create multifunctional “nanovehicles.” 
Gold “nanovehicles” are currently synthesized for noninvasive monitoring and treatment via 
fluorescent dyes or tumor-targeting ligands.30, 31, 32,23  
Despite the potentially advantageous features of NP drug delivery, the pharmacokinetics 
and toxicity of NPs remain uncertain.23,31 This uncertainty arises from a lack of understanding of 
how the synthetic and biological identity of NPs differ. In investigating this gap, researchers are 
currently testing some hypotheses on unviability of NPs as medical treatments. First, the 
immunogenicity of NPs33 suggests that their higher reactivity compared to conventional drugs 
may lead to hypersensitive reactions.34 AuNPs have been shown to have a shape-dependent 
role in antibody production and specific cytokine release. Of four AuNP shapes tested, 40 nm 
spheres induced more antibodies than a 20 nm sphere, or similarly-sized cube or rod.35 Second, 
NPs are hypothesized to form free radicals, which can cause biomolecular, oxidative damage in 
vivo.23 Third, the advantageous size- and surface-dependent properties of NPs may lead to 
accumulation, resulting in slow clearance of particles that may also increase opportunities for 
oxidative stress.33,34 For example, polymeric NPs around 25 nm travel through the lymphatic 
more readily than the larger particles. These 25 nm NPs can accumulate in lymph node resident 
dendritic cells.36  
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In this study, we address the formation of the protein corona, which is theorized to affect 
NP biocompatibility and stability in vivo.  The protein corona is simply defined as proteins from 
the human blood stream that adsorb to the NP surface. Scheme 1 summarizes potential 
physiochemical and biochemical effects of the formation of the corona. 
Although simplified in vitro environments are useful for determining whether a 
nanovehicle has been successfully designed, they provide limited insight into the behavior of the 
NPs in vivo. In vitro environments, such as lab solutions or one-model proteins, are simply not 
as complicated or viscous as in vivo environments. While we do not model agitation and blood 
flow in this study, we expose our AuNPs to human serum. Human serum entails largely albumin 
and globulin proteins found within blood, with the filtration out of erythrocytes and other cells. 
The reference range for total protein is typically 60–80 mg/mL, which contrasts to the typical 
exposure of fibrinogen and BSA of 1 and 10 mg/mL, respectively.1,5 Human serum (HS) 
proteome can be resolved chromatographically into 3700 separate protein spots through 2–
DE/immunoaffinity/size–exclusion chromatography. When these spots are analyzed for 
Scheme 1: Biological vs. Synthetic Identity of the NP with the formation of the protein corona. Adsorption of 
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sequence homology and through mass spectrometry, the HS profile can be reduced to 325 
distinct proteins.37 
Given the complexity of HS, many proteins will compete for the nanoparticle surface and 
form a protein corona.38  Because of AuNPs’ exceptionally large surface-to-volume ratios, more 
proteins — relative to the particle’s mass — may bind to the nanoparticle compared to larger 
particles and form the corona.39 Protein coronas are often considered either “soft” or “hard.” The 
soft corona entails loosely bound proteins of low-affinity, whereas the hard corona consists of 
tightly bound proteins with high affinity and long residence periods.38,40,41 Research currently 
suggests that the hard corona is more critical to the immunologic response and accumulation of 
NPs with organs.42,16 Given increased binding of the proteins to the NPs because of the surface-
to-volume ratio, the hard corona may constitute more of the NP’s biological identity than 
compared to other drug delivery techniques. The dynamic nature of this noncovalent protein 
corona is dependent on the charge, shape, and size of NPs. Further, the corona is widely 
theorized to determine the fate of the NP complex for several reasons: distribution, biophysical 
properties, and protein integrity.43 
First, the protein corona affects NP biodistribution throughout the body.44 Specific 
apolipoproteins have been demonstrated to increase distribution across blood-brain barriers, but 
also while correlating to rapid uptake within the liver and spleen.45,46 Protein adsorption has also 
been shown to induce an earlier immunological response.47 Uncontrolled protein adsorption that 
causes aggregation will also adversely affect NP in vivo trafficking, circulation, andcellular 
internalization, as well as potentially undermine the biomedical potential of these 
nanoparticles.16 Further, the corona may in turn prevent the NP from targeting the appropriate 
cells.48 On the other hand, the protein corona may reduce nonspecific cell uptake and NP 
toxicity.15,49,44,50-52 Second, the biophysical properties of the NP differs from the as-synthesized 
nanovehicle. The protein corona could mask the functional surface, inducing aggregation and 
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deactivating active sites.49,43,16 Third, NPs may also induce the loss of protein biological activity. 
Because proteins in the bloodstream adsorb to the NP surface, their functionality can also be 
compromised.53 
Given the role of the protein corona in the viability of NPs in medical application, 
researchers are now modeling in vivo conditions. These new studies progress from previous 
research on the interaction of the AuNP with the most abundant protein in human blood plasma 
or serum: albumin.54,55 Current research findings on protein-nanoparticle interactions can be 
organized into two categories: biochemical identification and physiochemical analysis of the 
protein corona. 
In regards to biochemical identification of the corona, researchers have demonstrated 
that kinetic and equilibrium binding parameters depend on protein identity, particle surface area 
and smoothness, and NP size.38 Methods like isothermal titration calorimetry (ITC) and surface 
plasmon resonance technology (SPR) are often relied upon to avoid possible perturbing effects 
of centrifugation. Centrifugation may disrupt protein-particle complexes or cause additional 
binding, in separating the soft from the hard corona.38 When investigating polymeric NPs, 
Cederwall et al. analyzed NP-associated proteins in plasma and simple model systems, albumin 
and fibrinogen, via ITC and SPR. The group determined that protein exchange rates depend on 
the copolymer nanoparticle hydrophobicity. When they are of higher affinity and slower kinetics, 
lower abundance proteins can displace human serum albumin (HSA) and fibrinogen from the 
nanoparticle surface. Further, many proteins were shown to competitively bind to and form 
transient complexes to copolymer NPs thiolyated to a planar Au surface.38 Similarly, another 
research group found that in analyzing specific binding kinetics of four major corona forming 
proteins (i.e., albumin, apoA1, fibrinogen, and polyclonal IgG), on-rates largely determined the 
component specific particle affinity for immobilized AuNPs.56 In addition to kinetics studies, 
researchers also enzymatically digest bound protein and then follow with mass spectroscopy. 
The application of this technique, however, has been largely limited to silica nanoparticles 
	 Cheema 12 
(SiNPs).56 As later described, my research uses this technique in elucidating the AuNP protein 
corona. One study applied complementary mass spectrometric techniques to AuNPs used three 
differently-sized citrate stabilized (i.e., “Bare”) models. The researchers found that a multilayer 
corona forms with 5–7 layers per 10 nm AuNP, while a monolayer forms for 60 nm GNPs — 
when exposed to human serum or 50 mg/mL bovine serum albumin.57   
In regards to physiochemical properties of the corona, Lacerda et al. have demonstrated 
that the thickness of the adsorbed protein layer increases with NP size.58 After exposing AuNPs, 
ranging from 5 to 100 nm, to common human blood proteins, the group analyzed the AuNPs 
through dynamic light scattering and electron microscopy. Although the exposed proteins 
concentration reflected normally found amounts, the NPs were only exposed to one-protein 
media.58 In investigating the role of the protein corona in stability, researchers used circular 
dichroism studies to demonstrated that HSA stabilizes Bare AgNPs against agglomeration. 274 
human serum albumin (HSA) molecules were determined to be necessary to coat a NP with a 
contact surface of ~32 nm.48 Consequently, only HSA concentrations necessary to form 
monolayers were used.  Corroborating results were also observed when Bare AuNPs were 
exposed to bovine serum albumin (BSA) by Dominguez-Medina et al. They found that a BSA 
monolayer stabilized the nanoparticles from aggregation in hypertonic NaCl conditions.59 As 
multilayer coronas are possible in complex media, such stabilization may not be similarly found 
in vivo.   
To reduce nonspecific protein adsorption, researchers are investigating various 
polymers that endow antifouling properties.60 The functionalization of AuNPs with polymers can 
stabilize the high–energy, negatively charged surfaces. Tethering biomolecules, like the FDA-
approved poly(ethylene glycol) (PEG), can increase biocompatibility, improve biodistribution, 
and extend the physiological half–life of AuNPs.61,62 Additionally, these polymers form an 
antifouling, stealth-coating that can serve as a platform for further functionalization beyond the 
gold surface. However, stealth-coatings are not entirely protein-proof. Researchers have shown 
	 Cheema 13 
there PEGylated AuNPs may acquire a significance amount of protein adsorption. Shorter chain 
PEG — 1k, 2k, or 5k — have been shown to be three to four times more effective than longer 
chains in shielding against nonspecific protein adsorption.56 
Although the highly hydrophilic PEG can reduce nonspecific protein absorption on the 
colloidal surface, its mechanism of protein resistance is not universally applicable nor robust nor 
fully understood.1 First, as precision medicine increases in need and availability, diverse stealth 
coatings must be considered for improved resistance against nonspecific protein adsorption and 
mitigation of anti-PEG immunity effects within the reticuloendothelial system.63 In response to 
these concerns, several groups have proposed various stealth coatings like the zwitterionic 
amino-acid polymer “PEK.” A repeating sequence of glutamic acid (E) and lysine (K), PEK can 
be easily attached to the surface of AuNPs through similar thiol-chemistry as that of PEG. 
Nonfouling peptides like PEK are advantageous because they form strong hydration layers as 
many zwitterionic materials do. Further, they rely upon natural instead of synthetic materials.5  
Second, both PEG and PEK have been shown to be somewhat successful in terms of 
biostability of AuNPs.1,5 Illustrated through UV–Vis spectroscopy data, AuNPs decorated with 
PEK also showed low or small variation in size when exposed to fibrinogen or positively-
charged lysozyme.5 Likewise, previous studies have shown that AuNPs functionalized 
Figure 1. PEG density influences serum protein adsorption to AuNPs and uptake into macrophage. Steric 
PEG-PEG interactions reduce PEG volume as density increases. Protein clusters are color-coded and are 
differentially adsorbed, depending on PEG density. Figure 5. from Walkey et al.6.  
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exclusively with PEG structures experience no change in effective size or zeta–potential when 
exposed to negatively-charged bovine serum albumin (BSA).1 However, these results are 
unrepresentative of in vivo environments, in which various proteins do adsorb to NP surfaces. 
Though a breath of research has been conducted on nanoparticle-protein interactions, 
these studies tend to be more representative of simple in vitro environments. Additionally, there 
is also a lack of research on how the conjugation of PEG or PEK alters the protein corona.57 
One study that did investigate human serum protein adsorption to PEGylated AuNPs did so at 
10% human serum.6 The group first demonstrated that 70 different serum proteins 
heterogeneously adsorbed to the surface of AuNPs. As shown in Figure 1, Walkey et al. then 
found that increasing the surface density of PEG reduced the amount of  protein adsorption, 
though such results depend on the AuNP size.6  
To better understand how models of in vivo-like conditions affect the behavior of the 
nanovehicles, we are investigating the formation and constitution of the protein corona around 
three different AuNP models: citrate-stabilized, MPEGylated and PEKylated gold.  Here, we 
assess the protein corona and stability of three AuNP models within increasingly enriched 
proteinenvironments through exposure to increasing concentrations of BSA, lysozyme and HS. 
As shown in Figure 2, MPEG is PEG with a methoxy terminal group opposite to the thiol 
terminus. PEK is a 4 nm long polymer (PyMOL) with an 
alternating sequence of five glutamic acid and four lysine 
units, followed by four prolines and a cysteine attached to 
an aminated C–terminus. This cysteine is then attached 
to the gold surface via the (sulfur) S atom in the side 
chain. The PEK polymer was specifically derived from 
research done by Nowinski et al., whereas PEG is 
commonly used.5 PEK has been shown to be ultralow 
Figure 2: Structures of peptides/polymers.  
(A) Methoxy–PEG (MPEG) thiol: 
100<n<150  
(B) poly(EK) (PEK): (EK)4EPPPPC–Amide, 
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fouling, as it forms a strong hydration layer that resists nonspecific protein adsorption.5 Nowinski 
et al. found that specific addition of –PPPPC linker allows for closer packing of PEK as 
monolayer and supports an ultra-low fouling behavior through a more uniform surface.5 Its 
negative charge has also been shown to minimize internalization and inhibit cellular uptake of 
NPs.64,65 Similar analogs have been used in AuNP photodynamic therapy.66 
To probe nanoparticle-protein interaction, we hypothesize that the type and quantity of 
proteins that form the corona will vary with among the three AuNP models: Bare, MPEG-, and 
PEKylated AuNPs. Zwitterionic PEK, given its ultra-low fouling, may reduce the amount and 
diversity of nonspecific protein adsorption to the NP more so than MPEG. Additionally, the 
protein corona may vary kinetically over exposure times and concentration of HS, where specific 
interactions to the NP will displace nonspecifically interacting proteins. Further, we expect to see 
a difference between the proteins that associate with the stealth-coating polymers and Au 
surface. Finally, as AuNPs are exposed to higher concentrations of HS, we expect to see 
AuNPs demonstrate reduce stability with the development of the protein corona. 
Scheme 2: Experimental Approach. AuNPs are synthesized with different stealth coatings and then exposed to 
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To investigate these questions, we first synthesized 11.2 nm Bare AuNPs, and then 
functionalized the surface by the coupling of thiol–terminated PEG or PEK. The samples are 
subsequently characterized with UV–visible spectroscopy, dynamic light scattering (DLS), and 
Zeta–potential to monitor size, charge, and uniformity.67 Second, as shown in Scheme 2, we 
evaluated protein resistance by incubating each AuNP model with negatively–charged bovine 
serum albumin (BSA) and positively–charged lysozyme. Adsorption can be successfully 
monitored with UV–visible absorption spectroscopy at 280 nm, at which tryptophan absorbs, for 
simple model biological fluids. We found that stealth–coating reduces protein adsorption and 
biofouling of the nanovehicle by both BSA and lysozyme; while in high concentrations, BSA may 
displace the MPEG coating.  
After initial investigation with model protein fluids, we subsequently evaluated the 
temporal and concentration-dependent formation of protein corona around each AuNP model 
through human serum exposure. We similarly exposed conjugated 50 nm maleimide-activated 
magnetic polystyrene beads to HS to determine if protein corona formation depends on 
polymers or gold surface. Investigating protein corona formation around beads also gives insight 
into how the stealth coating affects protein corona formation. As shown in Scheme 3, PEG 
molecules in particular adopt a brush-like conformation at high density. In conjunction with UV-
Vis and DLS, we used a nanoscale RP-HPLC/MS-MS to identify the proteins founds in the hard 
corona. The hard corona is likely acquiesced because of high-g centrifugation through a 
sucrose cushion during preparation steps. The sucrose cushion likely acts as a filter for low-
affinity proteins adsorbed to the surface.57 These techniques allow us to determine what 
proteins may constitute the corona. 
	 Cheema 17 
  
 
To understand how much protein adsorbed, we also normalized the protein amount to 
the gold concentration of each AuNP sample through inductively coupled plasmon optical 
emission spectrometry (ICP-OES). This technique of ICP-OES was also applied to determine 
the stability of AuNPs in protein solution in non-agitated and agitated conditions. Overall, our 
investigation addresses the type and quantity of proteins composing the hard corona and how 
that may differ by stealth-coating or over time. As of current research, the optimal design and 
chemical modification of NPs for in vivo use is unclear.43 Our investigation of the formation of 
the AuNP-protein corona in complex in vivo-like conditions provides insight to this field of 
research. Determining the properties and composition of the protein corona will allow the 
prediction of possible immunological and toxicologically relevant reactions, such as the uptake 
and accumulation mechanisms.68 This information will help improve NP engineering and design. 
 
Scheme 3. PEG 
molecules adopt brush-
like configurations at 
high density. Figure 1 is a 
3D schematic diagram 
courteously from Owens et 
al. (A) At low density, PEG 
chains adopt “mushroom” 
like configuration on 
polymeric NPs, remaining 
close to the surface. (B) At 
high density, PEG 
molecules extend away 
from the surface in a 
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Specific Project Goals: 
This thesis focuses on characterizing the protein corona formed around AuNP or bead 
models. It provides foundational work and insight into understanding how the corona may affect 
NP stability and efficacy. Research questions can be divided into three categories: 
1) Synthesis and functionalization of AuNPs and magnetic beads;  
2) Investigation of protein adsorption to AuNP surface through one-model protein systems; 
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II. Materials and Methods 	
All glassware was cleaned with aqua regia (3:1 concentrated HCl:HNO3) and rinsed with 
nanopure water (nH2O), purified to an 18.2 MΩxcm resistivity using an Easy Pure Water 
system. All aqueous solutions were prepared with nH2O with or without 0.1x phosphate buffered 
saline (PBS). A 20x PBS stock solution of 200 mM phosphate and 300 mM NaCl at pH of 7.23, 
was made from sodium chloride, sodium hypochlorate, and potassium hypochlorate in nH2O. 
The pH was adjusted with 6 M HCl or NaOH. 
  
a. AuNP Synthesis    
AuNPs were synthesized to 11.2 nm diameter through a reflux procedure using 50 mL of 
1 mM potassium gold (III) chloride (Aldrich, 1001809890) and 10 mL of 38.8 mM sodium citrate 
tribasic (Sigma-Aldrich, St. Louis, MO), as per procedure described in Flynn and Gewirth.69 After 
a one-hour reflux at 100 oC in a mineral oil bath, samples were cooled and then stored in vials 
wrapped with aluminum foil. As shown in Figure 3, 
distinctly wine-red colored AuNPs are formed. This 
color is specific to AuNP size. 
            AuNP stability and size were assessed using 
UV-Visible Spectroscopy (UV-Vis), Dynamic Light 
Scattering (DLS), and Zeta-Potential (ZP). UV-Vis 
spectra of AuNPs were acquired at a 1:10 dilution in 
nanopure water or 0.1x PBS on a Varyian Cary 500 
or Cary 100 Scan UV-Visible-NIR spectrophotometer 
in a 1-cm path-length cell (Agilent Technologies). 
Both spectrophotometers use a double-beam 
configuration and solvent baselines with experimental 
scans at a rate of 600 nm/min. Spectra ranged from 300 to 700 nm. Four-sided clear plastic and 
Figure 3. AuNP Synthesis. (A) KAuCl4 with 
positively charged metal ions of gold. (B) 
Citrate-stabilized AuNP solution. Wine-red is 
characteristic color of 11.2 nm AuNPs. 
Courtesy of Stephanie Schmitt ’13.  
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quartz cuvettes were respectively used for non-protein and protein samples. Bare AuNP 
absorbance reliably peaked at 519 nm. 
Before DLS and ZP were acquired on a Malvern Zetasizer Nano-2S (Zetasizer software 
6.12), samples without proteins were dispersed with a Branson Sonifier 250-450 Analog Cell 
Disrupter ultrasonic horn) at a 20–30% duty cycle and output control of 2–3. Samples were 
filtered with a 3.5 mL syringe through a 25 mm syringe filter with a 0.45 μm cellulose acetate 
membrane (VWR Scientific, 21845-479). Clear plastic fluorescence cuvettes or disposable 
folded capillary cells (DTS1070 from Malvern, Inc.) were used for DLS and ZP, respectively. ZP 
cuvettes were washed with 100% ethanol, air-dried, and rinsed nH2O vigorously before and 
after use. Capillary cells were used for a maximum of 10 times. Samples were thermally 
equilibrated for two minutes before experimental measurements, which were in triplicate. Data 
were fit to the Smoluchowski approximation in the Zetasizer software. Parameters for the 
standard operating procedures (SOPs) can be found in Table 1 and Table 2 for DLS and ZP, 
respectively. 
Table 1: Dynamic-light scattering parameters 
Dispersant Nanopure water, PBS 
Dispersant Viscosity (cP) 0.8872 
Dispersant Refractive Index 1.330 
Material Refractive Index 1.650 
Material Absorption 0.20 
Temperature 25 oC 
 
Table 2: Zeta-Potential scattering parameters 
Sample Material Gold 
Sample refractive index 1.650 
Sample absorption 0.20 
Dispersant 0.20 
Dispersant viscosity (cP) 0.8872 
Dispersant refractive index 1.330 
Dielectric Constant 78.5 
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b. Functionalization 
            A 300 μL aliquot of 20 μM of poly(EK), a polymer of (EK)4EPPPPC–Amide (MW = 1666.6 
g/mol) from Synthetic Biomolecules (0988-3605), was dissolved in nH2O and added dropwise to 
stirring 5 mL of bare, citrate-stabilized AuNPs. Alternatively, 1 mL of 2 μM of methoxy-
poly(ethyleneglycol)-thiol (MW = 5000 g/mol) from Laysan Bio, Inc., was added dropwise to 5 mL 
of AuNPs. Samples were stirred overnight at room temperature to ensure complete conjugation. 
UV-Vis, DLS, and ZP measurements were taken before and after functionalization. 
  
c. Purification of AuNPs 
After functionalization, particles were purified using centrifugation. For 5 mL samples or 
larger, 50 mL Nalgene Oak Ridge polypropylene copolymer centrifuges tubes were used. 
Samples were spun down in the Sorvall Lynx 4000 (ThermoScientific) centrifuge with A27-
6x50 rotor, at 43,478 rcf for 25 minutes, 10 oC. Samples were subsequently washed with 3 mL 
of 0.1x PBS after the removal of supernatant in each round. Samples with volumes less than 5 
mLs were purified in 1.7 mL Eppendorf tubes at 16,000 rcf for 20 minutes. Washing was 
repeated three times with 0.1x PBS. Supernatant was also spun down during the purification 
process to ensure maximal retention of AuNPs. UV-Vis, DLS and ZP measurements were taken 
before and after purification. 
  
d. Magnetic Beads 
50 nm maleimide- and carboxyl-functionalized super magnetic beads were purchased 
from NanoTech Ocean (MHM-050-05, MHP-050-05, respectively). A 2.5 mg sample of 
maleimide beads (5% lyophilized powder) was dissolved in coupling buffer (10 mM PBS, 5 mM 
EDTA, 0.01% Tween 20 (pH 7.2)). The sample was diluted with 0.1x PBS for a final 
concentration of 0.5 mg beads/mL. 1.25 mg MPEG or 0.42 mg PEK were each dissolved in 1 
mL and added to separate 5 mL samples. Samples were mixed overnight on an orbital shaker. 
Samples were purified thrice with 0.1x PBS washed using magnetic pull-down or centrifugation 
	 Cheema 22 
at 16,000 rcf for 5 minutes. UV-Vis was not run on the samples to determine protein content, 
given a 200–400 nm absorbance from maleimide polymer. DLS and ZP were also run on the 
samples. 
  
e. Dot Immunoblot Assays (Dot-Blots) 
Successful MPEGylation of magnetic beads was measured through dot blots. Magnetic 
bead and MPEG samples were spotted onto nitrocellulose membranes with positive controls 
(Anti-MPEG and 2 mg/mL MPEG) and negative controls (maleimide beads without MPEG, 
carboxyl beads exposed to MPEG, and 0.1x PBS). The membrane was incubated for one-hour 
in 15 mL blocking buffer (5% Blotting-Grade Blocker (Bio-Rad #170-6404) in Tris-buffered saline 
(TBS)).  Samples were then incubated in 1:1000 dilution of anti-MPEG antibody (RabMabs, 
PEG-B-47 antibody ab51257), which recognizes the terminal methoxy group of the PEG 
molecule. The membrane was exposed to the anti-MPEG antibody in blocking buffer for one-
hour at room temperature with shaking. After washing, the membrane was also exposed to 
1:5000 goat anti-rabbit IgG (H+L), conjugated horseradish peroxidase (HRP) (ThermoScientific, 
31460) for 30 minutes. Excess blocking buffer and antibody were removed through three 5–15 
minute washes with wash buffer (0.05% Tween 20 in TBS) and one 5-minute wash with 20x 
TBS.  Chemiluminescent visualization of HRP-tagged antibodies was stimulated with 
chemiluminescent substrate (Luminol Denville Scientific Inc. E2400) and was read on a BioRad 
GelDoc XR imager (100 second exposure on chemiluminescent protocol, 10 images). 
  
f. Bradford Assay and NanoDrop 
Bradford Assays were conducted according to the standard protocol listed in 
ThermoScientific Pierce Coomassie PlusTM Assay Kit (PI-23200). Absorbance measurements 
were taken at 595 nm through a microplate reader. Concentration of proteins were calculated 
and compared to a standard curve obtained by diluting 2 mg/mL Bovine Serum Albumin (BSA) 
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and Human Serum fit with a quadratic, with and without beads.* Standard curves with magnetic 
beads were also acquired, whereas AuNPs did not provide reliable curves for Bradford Assays 
or Modified Lowry (ThermoScientific, 23240). NanoDrop 2000 (ThermoScientific) 
spectrophotometer measurements were taken through the Protein A280 method with a 0.1x 
PBS baseline. Each experiment used a BSA standard of 2 mg/mL or a curve with a working 
concentration of 100 to 2000 μg/mL. 
  
g. Exposure of AuNPs or Magnetic Beads to Protein 
AuNPs were exposed to 1–10 mg/mL 96–99% bovine serum albumin (Sigma-Aldrich, A-
3350) or human serum albumin (Sigma-Aldrich, A-9511) overnight or between 1–12 hours at 37 
oC. AuNP samples exposed to BSA or lysozyme were centrifuged at 16,000xg  in the mini-
centrifuge for 18–20 minutes and then redispersed with 0.1x PBS. DLS, UV-Vis, Zeta-Potential 
or NanoDrop measurements were taken after exposure. Alternatively, NPs were also exposed 
to 1–5 mg/mL lysozyme (ThermoScientific, 89833) for similar incubation times. The volume of 
AuNP exposed remained constant. 
 
h. Human Serum 
50 mL pooled normal human serum was acquired from Innovative Research Inc. (IPLA-
SER-18322, expiration: 11/2018). Human serum was defrosted in warm water and gently 
stirred. Human serum was separated into 10 mL aliquots and frozen. Serum was either 





*  As advised in the ThermoScientific Instructions Manual for Coomassie Plus™ (Bradford) Assay 
(#23236), “If using curve-fitting algorithms associated with a microplate reader, a four-parameter 
(quadratic) or best-fit curve will provide more accurate results than a purely linear fit.” 
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i. Acquisition of the Hard Corona and NPs/Beads 
Human Serum at 100% or 20% were exposed to equal volumes purified bare, 
MPEGylated or PEKylated beads or AuNPs. Samples were incubated for 30 minutes at 37 oC. 
Samples were pipetted on top of an equal volume of 0.6 M RNAse-free sucrose cushion,57 and 
then centrifuged for 1.5 hours at a minimum of 18,000 xg at 4 oC in a Sorvall RC-5B 
Refrigerated Superspeed Centrifuge. A HB-4 swinging bucket rotor and Sorvall 13.2 mL 
polyallomer tubes (14x89 mm, thin-walled) were used with an appropriate adapter. One sample 
(10% HS & AuNPs, S2) was spun down in the Lynx centrifuge at a minimum of 18,000 xg. 
Supernatant was removed and the pellet was washed three times with 0.1x PBS, using the 
same centrifugation conditions for 5 minutes. Final sample was redispersed to 500 µL or 1 mL. 
Volumes were recorded for mass balance and NanoDrop readings were taken on every 
intermediate sample. This and the digestion of the NPs before Mass Spectrometry is 





Scheme 4: Proteomic Analysis of Corona. NPs or Beads are incubated with human serum for 30 minutes. 
Sample is centrifuged through a sucrose cushion at a minimum o 18,000 rcf. AuNP pellet is acquired and washed 
with PBS. NanoDrop measurements were taken throughout the washing step to mass balance proteins. Pellet is 










Stability and mass balance studies  
via ICP-OES and UV-VIS
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Digestion
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j. Digestion of the protein corona 
After acquiring the AuNP and its hard corona, the corona was then digested before 
running ICP-OES or RP-HPLC/MS. The following stock solutions were prepared: 0.4 M Tris with 
pH adjusted to 7.8 with 6 M HCl; 6 M urea, 100 mM Tris; 200 mM DTT, 100mM Tris; 200 mM 
iodoacetamide, 100 mM Tris; and, 40 ng/µL modified sequencing grade trypsin (Roche 
Diagnostics, 11418025001). AuNP sample was pelleted after acquisition of the hard corona 
through 13,200 rcf centrifugation. A 100 µL aliquot of 6 M Tris was added and the sample was 
gently vortexed for 15 minutes. Next, 5 µL of DTT was added and set for 1 hour. Subsequently, 
20 µL of iodoacetamide and 20 µL of DTT was added separately at hour-intervals. After these 
additions, 755 µL of cold nH2O was then added and followed by 100 µL of trypsin. Enzymatic 
digestion was left overnight at 30 oC. This protocol is based from Protein Sequencing and 
Identification using Tandem Mass Spec.70 
 
k. RP-HPLC/MS 
Following digestion, the sample was spun down and supernatant was run through a 
solid-phase extraction. A 5 mL sample of 50% acetonitrile-water with 0.1% formic acid was used 
to wet a syringe (BD 20 mL Luer-Lok™ Tip) and its attached 550 micron capillary coaxial (TMO 
72575); the solution was eluted with a vacuum assist. The syringe was washed twice with 5 mL 
of 0.1% formic acid. One mL of the sample was loaded and then allowed to drip. The syringe 
was additionally washed three times with 0.1% formic acid. Proteins were eluted with 700 μL of 
40% acetonitrile-water with 0.1% formic acid. Sample was then speed vacuumed down to 20 μL 
and then loaded into the RP-HPLC at acidic pH (75 µM by 20 cm column, packed with C18 
reversed phase material; flow rate of 0.25 µL/min). A trapping method was used to reduce 
experimental time. Samples were analyzed with the Top Ten method on Scaffold Q=/Q+S 
program using the Mascot and PEAKS studio by Eric Spooner at the Proteomics Lab at the 
Whitehead Institute (Massachusetts Institute of Technology).  Proteins were detected at a 99% 
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threshold, with a minimum of 2 peptides and peptide threshold of 95%. Data were extracted 
from the Scaffold program into Excel and leveraged to create a laboratory database that 
compared the sets of data across samples, studios and AuNP models.  
 
l. Inductively coupled plasma-optical emission (ICP-OES) 
Concentration of gold was determined by inductively coupled plasma-optical emission 
spectrometry (Optima 7000 DV, Perkin Elmer).  Samples were pelleted and the supernatant 
was removed. One mL of aqua regia was used to digest the pellet for 5 minutes. 7 mL of nH2O 
was added to the aqua regia mix and sample was left overnight at room temperature. Standard 
solutions for Au were prepared from a 100 ppm gold stock solution of KAuCl4 for a serial dilution 
of 0.001 to 20 ppm in 2% nitric acid.  An absorption wavelength 267.595 nm was used to obtain 
intensity values for the standards and sample.  Concentrations were normalized and calculated 
from a standard curve using the WinLab32 for ICP software (version 4.0.2.0380, Perkin Elmer).  
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III. Results and Discussion 	
This thesis focuses on characterizing the protein corona formed around AuNP or bead 
models. It provides foundational work and insight into understanding of the types and quantity of 
proteins that constitute the corona. 
 
The following section is divided into three categories: 
1) Synthesis and functionalization of AuNPs and magnetic beads;  
2) Investigation of protein adsorption to AuNP surface through one-model protein systems; 
3) Characterization of protein corona formation around AuNPs and beads in vivo-like 
conditions.  
 
Synthesis and functionalization of AuNPs and Magnetic Beads 	
A. Synthesis of Bare AuNPs and Functionalization with MPEG and PEK 
For our studies, we utilized 38.8 mM citrate to synthesize monodisperse, spherical 11.2 nm 
AuNPs, which we confirmed via Transmission Electron Microscopy (Schmitt, S. G., Wellesley 
College, 2013). While the data show in the Figures of this section from one sample of AuNPs, 
we produced several different samples of AuNPs throughout the course of this study. Thus, the 
data are shown representative. To characterize our AuNPs, we use three techniques: UV-
Visible spectroscopy, DLS, and Zeta-Potential. UV-Visible spectroscopy is especially useful for 
AuNPs as the surface plasmon resonances (SPR) depend on particle size and surrounding 
medium. In AuNPs, the mean free path of electrons is greater than the particle radius. 
Photoexcitation of the SPR produces an optical signature distinctive of AuNPs.71 DLS measures 
the size of NPs in a dispersion and provides data on the consistency of size between NPs via 
the polydispersion index (PDI). PDIs less than 0.3 suggest monodispersion or “uniform” particle 
populations. Bare AuNPs have been observed to have the lowest PDI, as low as 0.05 (data not 
shown). By measuring NPs’ random “Brownian” motion due to bombardment by solvent, DLS 
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can measure fluctuations in the intensity of measured light scatter over time. From this 
measurement, we can determine the translational diffusion coefficient,† which is relatable to 
particle size. Further, from data, we can also measure surface charge, or Zeta-Potential.72  
The spectrum in black in Figure 4 shows the UV-Visible absorption of Bare AuNPs. In Figure 
5, it shows the hydrodynamic diameter as determine by Dynamic Light Scattering (DLS). Our 
“Bare” AuNPs measure at an average diameter of 11.2 nm on DLS and peak UV-Vis 
absorbance at 519 nm. The dissolution of KAuCl4 in nH2O produces trivalent, positively-charged 
metal ions that are yellow in color.69 The reduction of gold ions into nanoparticles passes 
through an intermediary stage of colorless, uncharged gold atoms. The supersaturation of the 
solution results in precipitation and cluster formation, producing colloidal gold solution or citrate-
stabilized “Bare” AuNPs.73   
The addition of stealth coating through the thiol-chemistry based conjugated of PEK and 
MPEG increases stability and also serves as a platform for additional linkages (e.g., biotin-
avidin attachments of antibodies).5, 74-76 Further, it stabilizes the AuNP and may extend the Bare 
AuNP observed shelf-life of 6 weeks.77 While PEG is a common stealth coating, PEK was 
selected because of its ability to resist protein adsorption that results from its zwitterionic 
properties.5 MPEG is added at a concentration of about 2 mg/mL. PEK is added at 20 μM: a 
similar concentration to the minimum amount needed to stabilizes 20 nm AuNPs in NaCl salting 
experiments (Webb Lab). The rationalization of both concentrations is shown in Appendix A1 
and A2 respectively, which show PEKylation at 100 μM and 10 μM, as well as the double 
functionalization of MPEG.  
																																																								†	The hydronamic particle size of AuNPs can be determined by using the apparent translational diffusion 
coefficient, which is equivalent to the velocity of Brownian motion,  in the Stokes-Einstein equation: ! " = $%&'(). D is the translational diffusion coefficient, k is Boltzmann’s constant, T the absolute 
temperature, η the viscosity of the solvent used, and d(H) is the hydrodynamic diameter of particles.  	
	 Cheema 29 
The spectrum in red in Figures 4 and 5 shows UV-Visible absorption and hydrodynamic 
diameter of MPEGylated AuNPs, respectively. The spectrum in blue shows that of PEKylated 
AuNPs. The addition of MPEG increases the size of Bare AuNPs from 11.2 nm to between 30–
40 nm and results in a red shift in UV-Vis to 522 nm. The addition of PEK increases the NP size 
to an average size of 20–30 nm, with a red shift to 523 nm. Smaller shifts in wavelength are 
likely to suggest successful functionalization due to the change in the dielectric constant 
surrounding the particles and how it couples to the plasmon themselves. Larger changes in 
absorption wavelength and the distortion of the shapely spectrum, especially around 600—700 
nm are likely to suggest aggregation. Therefore, both DLS and Zeta-Potential are used to 
corroborate functionalization. The polydispersity index for Bare and MPEG remain at 0.3 or 
lower, while PEK has a higher polydispersity index of 0.5. Both polymers change the surface 





















Figure 4. Functionalization of AuNPs results in red shift in peak absorbance. 11.2 nm Bare AuNPs (black) 
were synthesized and then functionalized with 2 mg/mL MPEG (red) or 20 μM of PEK (blue) overnight. Samples 
were purified with 0.1x PBS and measured after a 1:2 dilution on the Cary 100 Scan UV-Visible-NIR 
spectrophotometer in a 1-cm path-length cell.  
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around –30 mV for Bare AuNPs to approximately –12 mV. The charge increase indicates the 
displacement of negatively-charged citrate ions from the surface by the less negatively-charged 
polymer. PEK is zwitterionic with a net negative of one, whereas MPEG is neutral. After 
PEKylation, the Zeta-Potential increases to –25 mV.  
Table 3. Functionalization of Bare AuNPs changes surface charge. Bare AuNPs were functionalized with 2 
mg/mL MPEG or 20 μM PEK. Samples were purified with 0.1x PBS. Zeta-Potential (Z.Pot) of the different AuNP 
models were measured on the Malvern Zetasizer in capillary cells. SOP parameters can be found in Table 2 of the 
Methods Section. 
AuNP model Structure (Charge) Z-Pot. (mV) 
Bare Citrate (−) −47.7 
MPEG MPEG (0) −11.6 
PEK  PEK (−) −25.6 
 
 
These measurements were taken after purification of the NPs with 0.1x PBS. The red and 
blue spectra in Figure 4 show the absorbance for purified gold nanoparticles coated with MPEG 
and PEK, respectively. Based on the absorption value we can calculate the yield from the 

























Figure 5.  Functionalization of Bare AuNPs results in size increase. 11.2 nm Bare AuNPs (black) were 
functionalized overnight with 2 mg/mL MPEG (red) or 20 μM PEK (blue) overnight and then purified (dashed) with 




20–30 nm 30–40 nm 
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batch of PEK, tends to result in poor recovery due to a removable impurity within the polymer 
not present in the first. Appendix A3 shows the MALDI-TOF data of the polymer, confirming 
PEK’s presence but also that of an impurity likely from the synthesis process performed by the 
manufacturer. This impurity is removed with purification in 0.1x PBS. 
 
B. Conjugation of Magnetic Beads with MPEG and PEK 
Hypothetically, proteins can adsorb to the polymer coating or the Au itself. To understand 
the corona’s dependency on a) the NP material (e.g., gold or polystyrene), and b) the coating 
and its density, we probed protein adsorption onto beads. This is largely motivated by findings 
of Walkey et al., who suggested that the corona depends on the density of PEG.6 As shown in 
Figure 1 (Introduction), Walkey et al. found that different clusters of proteins adsorbed to their 
AuNPs when exposed to human serum. By investigating adsorption to AuNPs with three 
different surface chemistries — citrate, MPEG, and PEK —  we are effectively looking at 
adsorption facilitated by the presence of both gold and a stealth coating. Gold is a highly 
reactive surface. Therefore, by investigating adsorption to MPEG- or PEKylated polystyrene 
beads, we could exclude protein absorption facilitated by gold. Moreover, we could also 
examine how protein adsorption depends on the density of our polymers coating NPs. 
We do not synthesize NPs other than variations of AuNPs. Thus, we selected the smallest 
commercially available beads to mimic the gold surface. Maleimide-coated magnetic 
polystyrene beads are capable of forming bonds with thiol-conjugated polymers like MPEG and 
PEK. Carboxyl-coated beads served as a control, but also had a negatively-charged surface 
that mimics Bare and PEK AuNPs. Consequently, beads allow for the investigation of both 
questions; they are made of a material other than gold and likely will not conjugate polymers at 
the same density as the NPs.  
The purple and black spectra in Figure 6 show the hydrodynamic diameters of carboxyl and 
unconjugated maleimide “Bare” beads. They were measured at an average hydrodynamic 
diameter of 60 nm and 70 nm, respectively. The retailer however sold the beads as 50 nm in 
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diameter, but measured via TEM (Appendix B1). This size difference could be due to a 
discrepancy in instrument measurement. Souza et al., found in comparing TEM and DLS data 
that DLS provided comparatively accurate results when using number distributions. However, 
DLS can produce higher values due to the presence of dispersants and the enlargement of size 
distributions.78 
 To demonstrate successful conjugation and purification, we used traditional methods of 
DLS, UV-Vis and Zeta-Potential. We first showed that our control, carboxyl beads, would not 
react with the MPEG polymer. The purple spectrum in Figure 6 shows the hydrodynamic 
diameter of carboxyl beads before and after exposure to MPEG under the same conditions to 
which maleimide beads were exposed. Even when carboxyl beads were exposed to thiolyated 
MPEG polymers and purified, there was no size increase. The blue spectra show the 
hydrodynamic diameter of PEKylated beads compared to Bare beads. Second, our DLS data 
demonstrated a size increase of 8 nm and 10–20 nm from Bare beads for PEK and MPEG-
conjugated beads, respectively (Fig. 6,7). As shown in blue spectra of Figure 7, DLS showed an 
8 nm increase in diameter, which is reasonable as our PEK polymer is 4 nm. Third, the red, 
dashed spectra in Figure 6 shows the diameter of reconjugated (i.e., double functionalization) 
MPEG beads, meaning that the beads were exposed to MPEG, purified and then exposed 
again and purified. The double functionalization of the MPEG beads showed moderate size 
increases of about an additional 8–10 nm. To determine if conjugation was consistent and 
reproducible, we repeated the reconjugation protocol with maleimide beads. MPEG and PEK 
data are shown in the red and blue spectra of Figure 8. Data shows that conjugation is 
reproducible and that reconjugation results in modest size increases.  
The spectra in Figure 9 show UV-Visible absorption of the beads, which were diluted 
extensively. All three maleimide bead models have notable absorption around 250–550 nm. UV-
Vis was therefore not particularly useful in observing any peak shifts. Further, because 
maleimide absorbs heavily around the 260—280 nm range, it would hinder a quantification of 
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protein concentration via aromatic amino acids. This observation motivated us to later use 
Bradford Assays on the beads, once exposed to protein (Methods D). Because of previous 
research demonstrating KI/I2 as a possible way to confirm the presence of MPEG (Appendix 
E1),61 we also exposed our MPEG-conjugated beads this etchant. When KI/I2 reacts with 
MPEG, it results in aggregation and a loss of peak at 500 nm. However, the etchant 
indiscriminately attenuated absorbance across all bead models, suggesting it interacts with 
maleimide or polystyrene in the beads. 
  





Figure 6.  Conjugation of MPEG polymers to Maleimide beads results in size increase. Maleimide “Bare” 
beads (black) were conjugated overnight with MPEG (red) overnight and then purified with 0.1x PBS. Beads were 
exposed and functionalized again (reconjugated) with MPEG (dashed red) in the same conditions. COOH beads 
(blue) were exposed to MPEG overnight and then purified with 0.1x PBS. Measurements were taken on the 






















Figure 7.  Conjugation of PEK polymers to Maleimide beads results in size increase. Maleimide “Bare” beads 
(black) were conjugated overnight with PEK (blue) overnight and then purified with 0.1x PBS. Measurements were 
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Figure 9. Magnetic Beads have general absorbance from 250 – 400 nm. Magnetic Beads were exposed to 1:1 






















































Figure 8.  Reconjugation of polymers to beads results in moderate size increase. Maleimide “Bare” beads 
were conjugated with polymers overnight. Samples were purified with 0.1x PBS, re-conjugated in similar 
conditions, and then purified a second time. Measurements were taken on Malvern Zetasizer.  	
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Given variability in DLS data, we explored different methods to confirm the conjugation 
our beads. As shown in Table 4, our Zeta-Potential data, suggested a change in surface 
chemistry. The addition of the slightly negative PEK polymer reduced the surface charge of the 
beads from –21 mV to –19 mV. The data are, however, not independently reliable, as our SOP 
parameters shown in Table 2 of the Methods Section were designed for non-magnetic AuNPs.	 
 
Table 4. Conjugation of Magnetic Beads changes surface charge. Maleimide “Bare” Beads were exposed to PEK 
overnight and then purified with 0.1x PBS. Zeta-Potential was measured in a capillary cell on the Malvern Zetasizer. 
Table 2 in the Methods Section provides SOP parameters.  
 
Magnetic Beads Zeta-Potential (mV) Cond (mV) 
Bare-Maleimide –21.2 32.0 
PEK-Maleimide –18.8 29.6 
 
 
 While our DLS and ZP data suggested PEK conjugation, we utilized a Dot Blot to 
confirm the presence of MPEG on our beads. An antibody for PEK was not available and 
therefore not considered. As shown in Figure 10.a., the first dot blot confirms the specific 
targeting of an anti-MPEG to the MPEG-conjugated beads. Using a secondary antibody with a 
HRP-tag for fluorescence, we confirmed the specific recognition of MPEG-maleimide (MPEG-M) 
conjugated with the antibody. The COOH bead dotted on the nitrocellulose was previously 
exposed and purified of MPEG at the same conjugation concentration, serving as a negative 
control (Fig. 6). In a second dot blot, shown in Figure 10.b, we investigated the uniformity of 
MPEG conjugation. Placing our MPEG sample over a magnet resulted in a separation, where 
some beads pulled down immediately and others remained dispersed in solution. We label 
these two different “phases,” as bottom and top of the sample, where the bottom, or pulled-
down beads, were more concentrated.  
In the second dot blot, we also introduced two more controls: MPEG AuNPs and loose 
MPEG polymer. Despite equal washing to that of the first, the second’s higher background 
signal is likely due to the diffusing of the loose polymer (Fig. 10b). Our blot demonstrates that 
both beads immediately pulled down and those remaining dispersed in solution have MPEG on 
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the surface. Future studies will however need to quantify the MPEG density difference among 
these beads. Nonetheless, all MPEG samples are detected, while our negative control of 0.1 
PBS was not. Having shown the successful conjugation of our beads, we then used these 




Investigation of protein adsorption to AuNP surface through one-model protein systems 
C. BSA and Lysozyme adsorption onto Bare, MPEG- and PEKylated AuNPs 
Prior to work conducted for this thesis, research focused on studying the adsorption of 
model proteins to Bare, MPEG, and PEK AuNPs. Schollbach et al. and Nowinski et al. 
investigated the presence of stealth coating in mitigating BSA and lysozyme adsorption on their 
AuNPs and gold self-assembling monolayers, respectively.1, 5  As shown in Fig. 11.a. 
Schollbach et al. observed changes within the surface chemistry of the NPs, as measured by 
Zeta-Potential, over one- and two-week exposure to varying concentrations of lysozyme: 0.05–5 
mg/mL.1 Nowinski et al., in studying self-assembling monolayers of gold, observed size 
increases after 10-minute incubations with 1 mg/mL of lysozyme or fibrinogen.5 Both groups 
observed protein adsorption decrease with NP functionalization, but also a change in surface 
chemistry of the NPs due to adsorption. Given differently designed AuNPs, we based our initial 
Figure 10. MPEG beads are successfully 
conjugated to beads. (A) Maleimide “Bare” 
beads (Bare-M) were conjugated overnight 
with either MPEG or PEK. COOH beads 
were also exposed. All beads were purified 
in 0.1x PBS after exposure. Controls 
includes: COOH, PBS and anti-MPEG. (B) 
MPEG AuNP was normally synthesized. 
MPEG-M beads were allowed to sit on a 
magnet to pull-down the beads. Aliquots of 
the top portion and bottom portion 
(concentrated) were also acquired. 10 
mg/mL of MPEG dissolved in 0.1 PBS was 
also spotted. Controls included 0.1x PBS 
(light green) and MPEG. Dot Blot was 
exposed to primary antibody anti-MPEG and 
then HRP-conjugated secondary antibody. 
Fluorescence was stimulated with 
chemiluminescent substrate and read on a 
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investigation on this research to ascertain if similar results could be observed. In order to 
understand a) if proteins adsorb to our AuNPs, and b) how they may change the characteristics 
of our AuNPs, we probed the interaction of BSA and lysozyme with our AuNPs. 
 
BSA and Lysozyme were selected as model proteins because of their well-characterized 
bio-physiochemical properties. As shown in Figure 12, BSA and lysozyme have two well-known 
structure. BSA has approximately 583 amino acids (i.e., 8 nm (DLS)) and lysozyme has 129 
amino acids (i.e., ~2 nm).2-3, 79 Further, BSA is negatively charged at –10 to –15 mV (pH 6), 
whereas lysozyme is positively charged at 4 mV (pH 6).79 Lysozyme also has 2 chloride ions 
involved in stabilizing its secondary structure, whereas BSA has three calcium-binding sites.2-3  
BSA is also homologous to highly abundant serum albumin found in human blood.80 Given the 
different surface charges of our AuNPs, electrostatic-based interactions are of particular interest 
Figure 11. Stealth-coating reduces 
protein adsorption. (A) Fig. 5 from 
Schollbach et al. shows size increase 
and change in Zeta-potential of 
Au20OEG60H particles after I) one-
week and II) two-week of exposure in 
varying concentrations of lysozyme.1 
(B) Fig. 2 from Nowinski et al, shows 
that protein adsorption and wavelength 
shift of peptide self-assembling 
monolayers is dependent on polymer 
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in protein corona formation.81 For example, Rezan et al. found that for moderately hydrophilic 
zirconia particles, significant protein adsorption still occurred despite repulsive electrostatic 
conditions and likely because of hydrophobic effects.82 Concentrations used in these studies 
were based on that used by Schollbach et al. They selected these concentrations as they were 
high enough to cover their 20 nm particles’ surface, but would minimize the impact on the bulk 
characteristics  (i.e., BSA’s maximum concentration was 10 mg/mL, whereas lysozyme was 5 
mg/mL).1, 5 For comparison, natural concentration of human serum albumin in blood is 35–50 
mg/mL83 and lysozyme in human milk is 8.2–34.5 mg/L.84 
 After exposure to BSA and then purification with 0.1x PBS, the surface charge of PEK 
AuNPs did not change significantly. MPEG’s surface charge became increasingly more negative 
with increasing concentrations of BSA (Appendix C1,C2). At 10 mg/mL BSA, MPEG’s Zeta-
Potential (ZP) decreased from –8 mV to to –22 mV, after filtration. Whereas, PEK’s surface 
charged remained at –26 mV, in the presence and absence of BSA.  This observation could be 
due to the closeness of PEK and BSA ZP’s.  
(A) (B) 
Figure 12.  BSA and Lysozyme are model proteins. Proteins are shown in secondary structures and color coded 
by hydrophobic (red) and hydrophilic (blue) residues. (A) Lysozyme consists of 129 amino acids and is positively 
charged. Chloride is in green. Image adapted from the RCSB PDB (www.rcsb.org) of PDB ID 1DPX. 2 (B) BSA 
consists of 583 amino acids and is negatively charged. Calcium is shown in green. Image from the RCSB PDB 
(www.rcsb.org) of PDB ID 3V03. 3 
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After exposure to 5 mg/mL lysozyme, PEK’s ZP increased in charge to 12.1 mV. PEK 
NPs darkened in color to purple, suggesting aggregation for intermediate concentration. 
Conversely, MPEGylated NPs surface charge increased to 3.5 mV from –8 mV (Appendix C3, 
C4). The data suggested that the adsorption of the protein was occurring and likely changing 
the surface chemistry of the AuNPs. 
 Interestingly, exposing the NPs to increasing concentrations of protein resulted in a size 
increase at low concentrations, and then size decrease at high concentrations. This data were 
collected after exposure, centrifugation and redispersion in 0.1x PBS. Additional work in 
incubating the NPs over 24 hour intervals with constant protein and AuNP concentrations 
demonstrated similar trends (Appendix C5). In observation, at high protein concentrations (i.e., 
10 mg/mL) and with a long incubation time (e.g., 24 hours), MPEGylated AuNPs sizes 
resembled that of Bare exposed to similar conditions (Appendix C5). This suggests, in 0.1x 
buffer or nH2O, that the stealth coating may either be displaced or, more likely, compressed. 
Similar observations were recently made with HSA and replicated trials with BSA and lysozyme. 
AuNPs exposed to HSA were not, however, filtered like those quantified in Appendix C5. The 
spectra shown in composite Figure 13, suggest that the adsorption of HSA to the surface of the 
AuNPs results in size decrease. The NPs become “smaller” with increasing concentrations of 
protein. The reduction in size of the AuNPs could be due to changes in surface chemistry, 
compression of the stealth-coating, or refraction by the polymer or loose protein. Given the 
consistency of these trends across incubation times, concentrations, and filtering, its not likely 
that changes between 0.1x PBS and nH2O effected hydrodynamic diameter observations in this 
case. This is a caveated supposition. Given the equations used in DLS, solvent and ionic 
strength can have pronounced effects on measured hydrodynamic diameters. 
Moreover, PEK itself is a 4 nm polymer (PyMOL) and should add 8 nm to the diameter of 
the Bare AuNP. MPEG (Mw = 5000) is estimated to have an extended length of 27 nm.85 Studies 
conducted by Chaudhary et al., on the adsorption of BSA to AuNPs without functionalization 
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suggested that BSA, a 9.5 nm protein — in their estimates — increases the size of the AuNPs in 
a monolayer.86 Therefore, they observed 8–10 nm increases, which somewhat match those 
observed with Bare. However, it does not follow that the size decreases observed with 
PEKylated AuNPs are reasonable. PEK is about half the size of HSA. Therefore, if protein were 
adsorbing to the surface or displacing PEK, a size increase should be observed.  
 
 To determine the amount of protein adsorbed to the surface, several methods were 
explored. First, conventional methods of colorimetric protein assays were explored for efficacy 
in the presence of AuNPs: Bradford, Modified Lowry, and BCA.  The Bradford Assay depends 
on the amino acid composition of the measured protein. Under acidic conditions, the brown dye 
of Coomassie Brilliant Blue G-250 is converted into its bluer form.87 Absorbance readings at 595 
nm were used to calculate protein concentration via a BSA standard (ThermoScientific No.	
23236).  The Modified Lowry Assay uses the reaction of protein with cupric sulfate and tartrate 



































































Figure 13. Human serum albumin may displace or compress the stealth-coating. Varying concentrations of 
Human Serum Albumin (HSA) were exposed to (A) Bare, (B) MPEG and (C) PEK AuNPs overnight at 37 oC. DLS 
measurements were taken on the Malvern Zetasizer after 1:1 dilution in 0.1x PBS. SOP parameters can be found 
in Table 1 of the Methods Section,  
(A) (B) 
(C) 
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Reagent reduces the complex to produce water-soluble blue products.88 Absorbance readings 
at 750 nm are utilized in calculations (ThermoScientific No. 23240). BCA was not considered, 
however, because its absorbance readings are measured at 562 nm, which is near the Bare 
AuNP peak.89 The assay, however, is commonly used by other groups studying protein coronas 
formed around liposomes.90 As shown in Appendix C6, experiments suggested Modified Lowry 
assays were sensitive to gold and could not be corrected for its presence. Similar observations 
were made for Bradford Assays, where a standard curve for BSA or Lysozyme could not be 
reliably acquired in the presence of constant amounts of Bare, MPEG or PEKylated AuNPs 
(data not shown). This could be due to procedural issues and errors caused by static balance 
associated with the weigh boat. BSA, however, produced somewhat better R2 values compared 
to lysozyme standards.  
 Therefore, we explored a simpler method of calculating relative protein concentration 
from amino acid absorbance from 260–280 nm.91 Tryptophan is found in most proteins and 
absorbs at 280 nm. Further, NanoDrop readers calculate protein concentration from dividing 
absorbance at 260 nm by that at 280 nm. Correcting to a BSA standard curve can provide 
insight into the relative concentration of protein in each of the samples. As shown in Figure 14, a 
standard curve for BSA and Lysozyme can be ascertained even in the presence of AuNPs and 
regardless of incubation time. AuNP is present at all concentrations in a 1:1 volume ratio, except 
at 20 mg/mL BSA and 10 mg/mL lysozyme. A 1:1 volume ratio does not mean the same amount 
of gold, given different retentions of MPEG- and PEKylated AuNPs during purification. Rather, 
this is a point for future improvement: to use ICP-OES to control for the amount of NPs in 
solution.  
R2 values remain at an average over 0.98, indicating strong trends. Further, a simple 
mass balance analysis through amino acid absorbance at 260–280 nm of protein content was 
performed. The error remained under 20%. (Appendix C7).  
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The relative amount of lysozyme or BSA protein per Bare, MPEG-, or PEKylated AuNP 
(ppm) was not calculated. In future trials, we will be able to make those calculations with UV-

























































Figure 14. Standard curves 
of proteins in the presence 
of AuNPs can be acquired 
at 280 nm. Samples of Bare 
(black), MPEG (red) or PEK 
(blue) were incubated at 
constant volumes with 
various concentrations of (A) 
lysozyme or (B) BSA for 1 
hour or 24 hours at 37 oC. 
Data points at 10 mg/mL 
lysozyme and 20 mg/mL 
BSA do not have AuNP in 
the sample. Incubation time 
does not significantly change 
the linear trend line. Trend-
lines were made with 1 hour 
samples. R2 values remain 
above 0.98. R2 values for 24 
hour trend-lines (not shown) 
remain above 0.85. 
Measurements were taken 
on the Cary50 Scan UV-
Visible-NIR 
spectrophotometer in a 1-cm 
path-length quartz cell. 
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Characterization of protein corona in vivo-like conditions 	
D. Human Serum and Preliminary Studies on NP Stability 
Having demonstrated that proteins adsorb to our AuNPs and may effect their identity, we 
proceeded to model increasingly in vivo-like conditions with human serum. Complex and dense, 
human serum posed new challenges in characterizing the interaction of AuNPs with protein. As 
shown in Tables 5 and 6, DLS measured an average particle size in human serum around 142 
nm, with a Zeta-Potential of –16 mV. In 1:1 volume ratios, we mixed AuNPs with 10% human 
serum. The measured DLS and Zeta-Potential of the serum did not change with the presence of 
AuNPs. This was similarly observed by Casals et al. who found that when exposed to serum, 
the average surface charge of their AuNPs (–45 mV) evolved to the serum average value (–10 
mV).92 However, the measured “size” of human serum is likely to be inaccurate, given the high 
polydispersity of the viscous medium. Despite its complexity, as the UV-Vis data shows in 
Figure 15, human serum demonstrated minimal to no attenuation of absorbance in the presence 
of the AuNPs models.  
Table 5. Human serum has a polydispersity index with a high average size. DLS measurements of 5% Human 
Serum exposed 1:1 with Bare, MPEG, PEK for 1 hour were taken. Sample was not sonicated or filtered but gently 
pipetted to mix. Measurements were taken on the Malvern Zetasizer. SOP parameters can be found in Table 1 of the 
Methods section. Zee 
DLS Z. Avg (nm) PDI Peak (diameters) 
Human Serum (HS) 141.7 0.9 224, 36, 1645 
HS + PEK 146.4 0.8 342, 22.57, 1450 
HS + MPEG 127.2 1.1 23.3, 690.4, 5482 
HS + Bare 153.5 0.6 31.25, 444 
 
Table 6.  Human serum has a negative “surface” charge. DLS measurements of 5% Human Serum exposed 1:1 
with Bare, MPEG, PEK for 1 hour were taken. Sample was not sonicated or filtered but gently pipetted to mix. 
Measurements were taken on the Malvern Zetasizer in a capillary cell. SOP parameters can be found in Table 2 of 
the Methods section. 
Zeta-Potential Zeta Pot. (mV) Zeta Dev. Conductivity Peak 
Human Serum (HS) -16.2 4.1 1.9 -16.2 
HS + PEK -15.9 5.2 2.8 -15.9 
HS + MPEG -16.1 N/A 2.3 N/A 
HS + Bare -18.1 4.0 1.7 -18.1 








Figure 15. AuNP does not attenuate human serum. UV-Visible measurements of 5% Human Serum exposed 1:1 
with Bare, MPEG, PEK for 1 hour were taken. Sample was not sonicated, diluted, or filtered but gently pipetted to 



















PEK + 5% Human Serum
Bare + 5% Human Serum
MPEG + 5% Human Serum
5% Human Serum
Figure 16.  Standard curves of 
Human Serum can be acquired 
at 280 nm. Varying concentrations 
of human serum were measured at 
280 nm. Trendlines were made 
with three samples. Average R2 
values remain above 0.98. 
Measurements were taken on the 
Cary50 Scan UV-Visible-NIR 
spectrophotometer in a 1-cm path-
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As shown in Figure 16, we could acquire a linear standard curve of the serum in presence 
and absence of our AuNPs at an absorbance of 280 nm with a R2 value of 0.98. This data 
involves a triplicate data set, suggesting the consistency of this data. 
We also attempted to use amino acid absorbance as a method of quantification of protein 
adsorption for magnetic beads. However, as shown in Figure 9, maleimide absorbs heavily in 
the 260–280 nm range.  Given the presence of maleimide on our magnetic beads, we opted to 
explore the Bradford Assay. As shown in Figure 17, we could acquire strong quadratic standard 
curves for human serum in the presence of our beads, with R2 values ranging from 0.85 to 0.97. 
Interestingly, the quadratic curve better fit the data in the presence of AuNPs. Unlike amino acid 
absorbance, which is dictated by Beer’s Law, Bradford Assays use quadratic standard curves.‡ 
A BSA standard curve is provided in Appendix D1. 																																																								
‡  The ThermoScientifc Instructions for Coomassie Plus™ (Bradford) Assay (23236) states, “When 
compared to the Standard Test Tube Protocol, 595nm measurements obtained with the Microplate 
Protocols are lower because the light path is shorter. Consequently, this may increase the minimum 
detection level of the assay…If using curve-fitting algorithms associated with a microplate reader, a four-
Figure 17.  Bradford Assay standard curves can be acquired in the presence of AuNPs. Various 
concentrations of human serum were exposed 1:1 in volume to constant volumes of Bare, MPEG, and 
PEKylated AuNPs.  ThermoScientific microplate assay protocol was followed in acquiring absorbance volumes 
at 595 nm. Plate was read on a microplate reader.  
y = -0.0201x2 + 0.3636x + 0.1348
R² = 0.92732
y = -0.023x2 + 0.4144x + 0.1402
R² = 0.94659
y = -0.0248x2 + 0.4257x + 0.0733
R² = 0.97018





















HS + Bare beads
HS + MPEG beads
HS + PEK beads
Human Serum
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An additional course of experiments explored the stability of our AuNPs in human serum. To 
understand how the adsorption of protein may change the stability of AuNPs, we exposed our 
NPs for various time periods to either 10% or 50% human serum. Samples were mixed before 
separated into time-point aliquots. We then separated the sample by top, middle, and bottom 
layers, each consisting of 33% of the sample. We measured the protein concentration via 
NanoDrop of the top and bottom layers relative to a BSA standard. After centrifugation, we 
removed the supernatant and digested the protein from the NPs. We then removed this 
supernatant and digested the NPs in Aqua Regia. As shown in Figure 18, ICP-OES readings of 
[Au] were taken at different time points and concentrations. Over time, our AuNPs exposed to 
HS seem to undergo a “density separation;” however, more experiments will need to be 
performed to understand whether AuNPs are adsorbing protein are becoming “heavier” or less 
evenly dispersed within the solution. In general, the AuNPs, as measured by their [Au] post-
digestion, seem to become more concentrated in the bottom layer of the vial. Positive percent 
changes indicate there was more [Au] measured in the bottom, compared to the top layer. [Au] 
in ppm were calculated from absorbance at 267.595 nm, according to a standard curve found in 
Appendix D2.  
																																																																																																																																																																																		
parameter (quadratic) or best-fit curve will provide more accurate results than a purely linear fit. If plotting 
results by hand, a point-to-point curve is preferable to a linear fit to the standard points.” 




























































































(B) Incubation with 50% Human Serum
Figure 18. AuNPs generally show a phase separation during incubation with human serum. (A) 10% 
human serum and (B) 50% human serum were incubated 1:1 with constant volumes of Bare (black), MPEG 
(red), and PEK (blue) AuNPs at 37 oC for 30 minutes, 4 hours, or 24 hours. Samples were then separated into a 
bottom, middle and top layer (33% of the sample). The bottom and top layer were spun-down and pellets were 
digested through the Method j.  and then with Aqua Regia. Samples were diluted 1:7 to 8 mL in nanopure water. 
Measurements were taken and normalized by Optima 7000 DV, Perkin Elmer. Absorbance was read at 267.595 
nm and then using a standard curve, calculated into [Au] (ppm). Significant differences in [Au] between bottom 
and top layer were calculated within the same sample. 
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E. Determination of Amount of Protein Adsorbed  
AuNPs and beads were incubated with 10% or 50% Human Serum for 30 minutes. Both the 
10% human serum incubation and the time interval conditions were found in the literature.17, 44, 57 
The 50% Human Serum condition was used to model increasingly in vivo-like conditions.  Given 
the viscosity of human serum, acquiring only adsorbed proteins to the NPs required multiple 
washes and centrifugation through the sucrose cushion. The cushion captures loose proteins. 
This method was adopted from Iglesias et al. who found that a sucrose cushion, in addition to 
multiple washing steps in 0.1x PBS, was more effective then only washing with 0.1x PBS.57 50% 
Human Serum samples, however, required one additional step of washing than 10% HS 
samples did. While human serum does not pellet, NPs will pellet with adsorbed proteins. 
Through this process, we can acquire NPs and their “hard” corona. 
In order to first identify the proteins, we explored different ways to digest the corona. First, 
we decided against Aqua Regia to digest the NPs, as we would not be able to separate the gold 
ions from the protein. We explored using a KI/I2 etchant to digest the AuNP and release the 
corona.61 The etchant, however, reacts with both MPEG and Au, resulting in aggregation, and 
has no clear trend at 280 nm (Appendix E1). Third, we used a combination of 8 M Urea and 2% 
CHAPS (Appendix E2). Again, we attempted to track the total mass of protein across all 
portions of the sample, particularly during washing steps. We could mass balance BSA and 
lysozyme proteins within 15 percent, but ultimately stepped away from 2D gels for identifying 
proteins (Appendix E3). Gels would likely result in a smear of indiscernible proteins, given the 
serum complexity. Instead, we used the Sherman Digestion, as described in Method J. This 
digestion effectively removed proteins from the surface of the NPs and beads. However, as 
shown in Table 7 and 8, digestion results in the aggregation of the NPs and failure to recover 
NPs after digestion. This is demonstrated by huge increases in hydrodynamic diameter. As 
shown in Figure 19, the digested particles, once redispersed, do not have characteristic peaks 
of AuNPs. 
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Table 7. AuNPs retain surface charge moderately after digestion. Bare, MPEG and PEK AuNPs exposed to 10% 
Human Serum were pelleted through a sucrose cushion and then digested via the Sherman Digestion. Supernatant 
containing proteins was removed and samples were washed once in 0.1x PBS and redispersed. Samples were 
sonicated and filtered. Representative samples of AuNPs (i.e., original) are included for comparison. Zeta-Potential 
Measurements were taken on the Malvern Zetasizer with SOP parameters listed in Table 2 (Methods).  
AuNP type ZP (mV) ZD Cond (mV) Peak (mV) 
Bare (original) –34.5 65.7 1.35 –34.0 
Bare (digested) –28.3 17.9 3.4 –30.5 
MPEG (original) –0.67 27.1 2.39 –3.53 
MPEG (digested) –17.8 10.7 3.0 –24.5/–6.02 
PEK (original) –26.5 10.2 2.44 –26.5 




Table 8. AuNPs cannot be recovered after digestion. Bare, MPEG and PEK AuNPs exposed to 10% Human 
Serum were pelleted through a sucrose cushion and then digested via the Sherman Digestion. Supernatant 
containing proteins was removed and samples were washed once in 0.1x PBS and redispersed. Samples were 
sonicated and filtered. DLS Measurements were taken on the Malvern Zetasizer with SOP parameters listed in Table 
1 (Methods). Diameter (d.nm) 
AuNP type Z. avg (nm) PDI Peak (d.nm) 
Bare 924.73 0.70 506.97 
MPEG 1452.67 0.71 1183.67 
PEK 876.33 0.71 896.10 
 
Figure 19. AuNPs cannot be recovered after digestion. Bare, MPEG and PEK AuNPs exposed to 10% Human 
Serum were pelleted through a sucrose cushion and then digested via the Sherman Digestion. Supernatant 
containing proteins was removed and samples were washed once in 0.1x PBS and redispersed. UV-Visible 
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In Figure 19, the dampened absorbance may suggest aggregation or the complete fall-out of 
MPEGylated AuNPs from solution. This is shown as the resonance not only red-shifts, but also 
broadens and disappears with progressive agglomeration.92 Further, the presence of organics at 
225 nm can clearly be seen despite washing in 0.1x PBS. Organics were present in high 
concentrations during the Sherman digestion. Irreversible aggregation was reasonably expected 
given the harsh reducing stages of the digestion, which can result in precipitation of the colloidal 
gold. Interestingly, although removing the corona results in irreversible aggregation, its 
adsoprtion may help with stability. Some have theorized that the corona will reduce particle 
agglomeration in serum. Long incubation times allow for stronger binding of proteins to the 
surface, preventing desorption in serum free media.92 
Having established Amino Acid Absorbance as a method to quantify protein concentration, 
and ICP-OES to determine [Au], we then focused on determining the concentration of protein 
found in the corona. To do so, we first measured amino acid absorbance of our samples before, 
during, and after spin-down. Continually monitoring of the proteins allowed us to determine the 
efficiency of process and technique. Our mass balance, as shown in Table 9, was calculated by 
comparing the original absorbance of our human serum and AuNP sample to that of the pellet 
and accumulated supernatant. This required multiple corrections for the sucrose cushion as well 
as volume changes during washes. Our percent error ranged between 8 and 20 percent for 10% 
Human Serum. Factor adjustments used can be found in Appendix E4.   
Table 9. Proteins can be mass balanced during acquisition of the protein corona. Samples of Bare, MPEG, 
and PEKylated AuNPs were incubated with 10% Human Serum and then spun through a sucrose cushion at 18 xg. 
Pellets were washed three times with 0.1x PBS and then redispersed. At the step, absorbance at 280 and 260 nm 
were acquired on the NanoDrop 2000. Relative protein concentration was calculated by diving A260/A280 and 
corrected to a 2 mg/mL BSA standard. Percent differences compare the sum of pellets and washes to the protein 
concentration measured in the original sample. MPEGylated AuNPs are less efficient at spinning down than Bare or 
PEKylated AuNPs.  
Sample  Comparison % DIFF 
20%HS (1:1 theoretical dilution) 10% HS –8.2% 
10% HS + Bare  
Adjusted Sum of Pellet and Washes 
Supernatant –8.2% 
10% HS + MPEG 
Adjusted Sum of Pellet and Washes 
Supernatant –21% 
10%HS + PEK 
Adjusted Sum of Pellet and Washes 
Supernatant –12% 
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By adjusting the final concentration of sample to 2 mg/mL BSA standard, we could acquire 
an approximate concentration of protein via the NanoDrop. Second, we measured the [Au] in 
the sample by running ICP-OES on the second 10% HS sample (retrieved to the Whitehead 
Institute), as well as 50% Human Serum sample prepared under similar conditions. These 
samples were digested before ICP-OES. We then compared this protein concentration to the 
[Au] found in the sample, after digestion. From this data, we first calculated the relative 
concentration of protein found in MPEG and PEK samples compared to that of the Bare 
Sample. As shown in Table 10, there is variability between the samples in [Au] and protein 
concentration, even in similar samples. Samples with asterisks indicate that they were analyzed 
for protein type through mass spectrometry, which is shown in the next section. Some samples, 
post RP-HPLC/MS, were not run through ICP-OES due to loss of the sample. Given the need to 
normalize the data to both a BSA standard, as well as to one for ICP-OES, we compare the 
relative amounts of proteins in each sample. PEKylated sample data suggests that the model 
has more protein adsorbed to it surface, whereas Bare has the least.  
 
Table 10. PEK has more protein per nanoparticle than other models. Samples of AuNPs were exposed to 
various concentrations of human serum. All samples were pelleted through a sucrose cushion, washed, and digested 
via the Sherman digestion. Samples were then digested with Aqua Regia and nanopure water 1:7 before ICP-OES 
measurements were taken on the Optima 7000 DV. [Au] in ppm were calculated from absorbance at 267.595 nm via 
a standard curve. Protein concentrations in to-be digested pellets were measured on NanoDrop 2000 and corrected 
to a 2 mg/mL BSA standard. Some pellets’ protein coronas were also analyzed via RP-HPLC and are labeled with 
asterisks.  
Model [Au] (ppm) Protein (mg/mL) [Protein]/[Au] (mg/ppm) Ratio to Bare 
50%HS – PEK (Sample 2)* 0.70 2.9 4.2  
50% HS + Bare 15.2 4.1 0.24  
50% HS + MPEG 5.58 1.8 0.28 1.2x 
50% HS + PEK 1.14 1.9 1.4 6.0x 
10% HS + Bare* 0.38 1.3 3.3  
10% HS + MPEG* 0.099 0.79 7.9 2.4x 
10% HS + PEK* 0.15 2.0 13 3.9x 
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To provide a more illustrative analysis of the data, we also calculated the protein corona 
thickness. Using the three equations below, we calculated the thickness, factoring in the 
average size of the nanoparticle. Additional factors and values used within this calculation can 
be found in the Appendix E5.  
 
Equation 1:  *+,-./0: 234* = 5678	 :;76)<6= 	(?@?A)C5D	8678.		(?@?A)  
Equations 2:  FG	,H =<6IJK7L7KI	;<J; ,H	234* = =<6IJK7MNOP?Q?ARL:D	SPTUVWQ	VTQV?A  
Equation 3:  *+,-./0	-ℎ/FY0.ZZ = FG	,H =<6IJK7L7KI	;<J; ∗ \∗\]^7_8_  
 
 
Table 11. PEK has a thicker protein corona than other models. Samples of AuNPs were exposed to various 
concentrations of human serum. All samples were pelleted through a sucrose cushion, washed, and digested via the 
Sherman digestion. Samples were then digested with Aqua Regia and nanopure water 1:7 before ICP-OES 
measurements were taken on the Optima 7000 DV. [Au] in ppm were calculated from absorbance at 267.595 nm via 
a standard curve. Protein concentrations in to-be digested pellets were measured on NanoDrop 2000 and corrected 
to a 2 mg/mL BSA standard. Some pellets’ protein coronas were analyzed via RP-HPLC and are labeled with 
asterisks. Protein thickness was calculated from Equations 1, 2, and 3. Additional constants used can be found in 
Appendix E5. 
Model Protein Thickness (nm) Thickness compared to Bare Sample 
50%HS - PEK (Sample 2)* 5.0E+05  
50%HS - Bare 1.5E+04  
50%HS - MPEG 6.3E+04 4.3x 
50% HS - PEK 2.7E+05 18x 
10% HS - Bare* 1.8E+05  
10% HS - MPEG* 9.5E+05 5.3x 
10% HS - PEK* 1.6E+06 8.8x 
*Analyzed via RP-HPLC/MS 
 
As shown in Table 11, the thickness of the corona does vary, but stays within a range of 
104–105 nm. Expectedly, PEKylated samples seem to have much thicker coronas — a 
difference that becomes more pronounced in higher concentrations of human serum. If 
plausible, the thickness suggests a multiple-layered corona to an extreme sense of it and the 
agglutination of proteins. Lacerda et al. found that the corona thickness increases with the size 
of AuNPs when incubated with one-model proteins systems: HSA, fibrinogen, y-globulins, 
histone (H3), and insulin. Each protein was observed to coat the particle with a thickness of 
approximately 50 nm as calculated through DLS data.58 Comparatively through TEM, 
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Fernandez-Iglesias et al. found that a 3 nm thick monolayer formed around 60 nm AuNPs, 
whereas 30 nm AuNPs has a corona thickness of 7–8 nm when exposed to BSA. When 
exposed to human serum, 10 nm AuNPs had 5–7 protein layers forming the corona, while larger 
particles had fewer layers.57 Each layer likely consists of around 10 nm, meaning that the total 
corona has a thickness between 50–70 nm. 
In addition, while we could not calculate the amount of protein per unit of polystyrene 
magnetic bead, we were able to run preliminary calculations on the amount of protein in each 
magnetic bead sample submitted for RP-HPLC/MS at the Whitehead Institute. This is largely 
because we do not have a protocol for an ICP-OES equivalent to determine the amount of 
polystyrene in a sample. As shown in Table 12, we determined the percent of human serum and 
μg/mL protein in a pelleted sample through standard curves acquired through the Bradford 
Assay. The assay uses a quadratic standard curve, but a linear curve was also used to 
calculate the relative amount of protein in the sample. The equations used are listed in Figure 
17 of Section D. Samples were exposed to human serum and then washed to acquire the hard 
corona, in an equivalent procedure to that performed on NPs. Interestingly, Bare beads seem to 
retain the most protein in sample, while MPEG retains the least amount of protein in its sample. 
This, however, does not mean there is more protein per bead, as we do not yet have a way to 
quantify for bead concentration in the pellet. Therefore, while we can say there is more protein 
in the Bare sample, we cannot say there is more protein adsorbing to a Bare bead compared to 
a MPEG bead. 
Having preliminarily quantified the amount of protein that may stick to various AuNP models 
and beads, we then investigated the types of proteins that constituted the corona. Knowing the 
types of proteins that adsorb can help inform designs of NPs into order to prevent their 
adsorption. For example, if proteins adsorb electrostatically, then NPs can be designed to 
oppose adsorption via surface charge. Further, if proteins constituting the corona change over 
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time or concentration, we can then ask questions regarding if corona is kinetically-driven. We 
explore these and other questions, as we identify the proteins constituting the corona.  
 
Table 12. Bradford assay can be used to measure protein concentration in magnetic beads. Magnetic beads 
were exposed to 50% Human Serum for 30 minutes, pelleted through a sucrose cushion, and then washed thrice 
with 0.1x PBS. ThermoScientific Bradford Assay microplate assay protocol was used to measure the concentration 
of protein in the samples at 595 nm. Beads without protein were measured to acquire correction factors. Corrected 
absorbance are marked with asterisks. Linear and Quadratic curves for 2 mg/mL BSA standard curve and 10% 
Human Serum were used to calculate protein concentrations from absorbance readings. 
  LINEAR QUADRATIC QUADRATIC 




(BSA μg/mL) % (HS) 
Bare beads 0.203 120 110 0.3 
MPEG beads 0.12 68 58 0.0 
PEK beads 0.056 25 17 -0.2 
COOH beads 0.031 9 2  
100% HS 0.982 640 790 Exceeds limit of detection 
50% HS -Bare 0.525* 340 350 1.1 
50% HS - MPEG 0.27* 170 160 0.4 
50% HS - PEK 0.412* 260 260 0.7 
50% HS - COOH 0.409* 260 260 0.7 
 
 
F. Identification of Proteins Constituting the Corona 
Four sets of samples were submitted to the Proteomics Lab at the Whitehead Institute (MIT) 
in order to acquire RP-HPLC/MS data on the protein corona. First, two sets of Bare, MPEG, and 
PEK samples were exposed to 10% human serum for 30 minutes. These samples were 
prepared under the same experimental conditions except for two factors. First, new AuNPs were 
synthesized and functionalized for each sample. This was necessary because of the shelf-life of 
the AuNPs. In addition, using different batches of similarly produced AuNPs provides insight into 
the reproducibility of the data acquired. Second, the second sample (S2) for 10% human serum 
was spun down at a minimum of ~18,000 rcf with the Lynx not Sorvall centrifuge, given an 
enduring machine malfunction. Third, one sample of AuNPs exposed to 50% human serum 
were delivered. The samples were also made with new AuNPs. Fourth, one sample set of 
carboxyl, maleimide-activated, MPEG-conjugated, and PEK-conjugated beads exposed to 50% 
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human serum were submitted. Samples were run through a sucrose cushion, washed and then 
digested to remove proteins from the surface of the NPs.  
After acquiring data from the mass spectrometer, the samples were analyzed through two 
databases: PEAKS and Mascot. Both are proteomics software that are commonly used to 
identify proteins through tandem mass spectroscopy data, using the same raw data. This 
analysis was loaded onto Scaffold Program, which provides a visual analysis of proteins (i.e., 
Protein threshold=99%, min. peptides=2, and peptide threshold=95%). Using the Scaffold 
Program to analyze the MS data, we were able to determine the number of proteins that 
constitute the corona. We then downloaded these files into Excel to do our own analysis. In our 
study of the proteins, we looked at either the Mascot data files and a merged file of both 
algorithm research results. We favored Mascot over PEAKS because of an inconsistent 
information transfer of PEAKS studies search results into Scaffold. Unexpectedly, some proteins 
were very abundant in the Mascot search, but totally absent in the PEAKS search, particularly in 
the beads sample set. This is important as it results in different numbers in the Venn Diagrams 














10% HS exposed NPs (Sample 1) 50% HS exposed NPs
Bare MPEG
PEK
10% HS exposed NPs (Sample 2)
Figure 20.  Differing AuNP models share common core of proteins found in corona. Samples of AuNPs were 
exposed to various concentrations of human serum: Bare (black), MPEG (red), and PEK (blue). All samples were 
pelleted through a sucrose cushion, washed, and digested via the Sherman digestion. Samples were pelleted and 
protein supernatant was washed through a solid-phase extraction before loaded onto a reverse-phase C18 column 
for HPLC. Mass Spectroscopy was then run at the Whitehead Institute Proteomics Labs. Data were run through 
Mascot and PEAKS studio and loaded onto the Scaffold Program (Protein threshold=99%, min. peptides=2, and 
peptide threshold=95%). Venn diagrams reflect proteins found within both databases.  	
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As shown in Figure 20, most models of AuNPs share a common set of proteins, while there 
is some variability between the models. These Venn diagrams were created from loading both 
Mascot and PEAKS data files into Scaffold. Appendix F1 and F2 lists the proteins only found 
within on each AuNP model, across samples and at 
10% and 50% HS.   
Additionally, we investigated the type of proteins that 
constitute the corona around magnetic beads. By 
examining magnetic beads that were similarly 
conjugated, we could elucidate the dependency of 
corona constitution on the stealth coating density of NPs 
and provide insight into the role of thiol-reactive gold in 
protein corona formation. As shown in Figure 21, there 
is minimal variation between Bare and carboxyl beads. 
Interestingly, the magnetic beads compared to AuNPs 
seem to have more different types of proteins adsorbing 
to the surface. The difference between NPs and beads 
samples could be due to the surface density difference 
between MPEG and PEK surfaces. Moreover, the 
difference between 10% samples could be due to minor 
experimental differences, while the difference between 
10% and 50% samples could also be due to kinetics. 
Generally, most studies have shown that over time of 
exposure, low abundance, high-affinity proteins will outcompete high abundance, low affinity 
proteins on the corona.93 For example, human serum albumin constitutes a majority of serum, 
but may become less relevant to the corona in high concentrations or during long incubation 











Figure 21, Differing Bead models share 
common core of proteins found in corona. 
Samples of magnetic beads were exposed to 
50% human serum: unconjugated maleimide 
“Bare” (black), MPEG (red), PEK (blue), and 
COOH (purple).  All samples were pelleted 
through a sucrose cushion, washed, and 
digested via the Sherman digestion. Samples 
were pelleted and protein supernatant was 
washed through a solid-phase extraction 
before loaded onto a reverse-phase C18 
column for HPLC. Mass Spectroscopy was 
then run at the Whitehead Institute 
Proteomics Labs. Data were run through 
Mascot and PEAKS studio and loaded onto 
the Scaffold Program (Protein 
threshold=99%, min. peptides=2, and peptide 
threshold=95%). Venn diagrams reflect 
proteins found within both databases.   	
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 To further analyze why certain types of proteins constituted the corona, three 
characteristics or biochemical properties of the proteins were considered: abundance in serum, 
molecular weight, and electrostatics. First, as seen in Figure 22, the protein fingerprint 
according to relative abundance somewhat differs according to the AuNP model. A similar 
observation can be made in Figure 23 for magnetic beads. The heat maps visualize difference 
in relative protein abundance via percent of total spectra data. This is synonymous to 
Quantitative Value, and is assumed to be indicative of the relative percent abundance of the 
protein in the corona. This is an important assumption as we cannot confirm that all proteins 
were successfully, equally, and completely digested from the samples before RP-HPLC/MS.  
Further, the amount of peptides per protein found in mass spec data are dependent on the 
number of sites for tryptic digests and the size of the protein. A PEAKS search parameters 
allows for one non-tryptic end on peptides and likely increases the number of peptide IDs when 
compared to Mascot. Therefore, the total percent of spectra will vary between studios and 
abundance must be considered as a relative value. Though Quantitative Value does not control 
for molecular weight, it does normalize the values; the data are not dependent on the amount of 
total protein analyzed between samples.§  
In the Figure 22 and 23, the data visualizes proteins constituting greater than 0.1 percent 
of the corona, according to Mascot values. Heat maps of PEAKS data can be found in Appendix 
F3 and F4. Observably, higher concentrations of human serum result in less diversity of proteins 
found in high abundance. Additionally, each AuNP model has generally different proteins in 
relative abundance. There is however variation between samples. For example, Bare and PEK 
in sample 1 of 10% Human Serum condition differ from models prepped similarly in sample 2.  
 
																																																								§	The white paper explaining quantitative in Scaffold can be found here: https://proteome-
software.wikispaces.com/file/view/White_paper_precursor_intensity_quantitation_scaffold_Q_plus.pdf	
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The types of proteins that constitute the corona vary among AuNP models minimally, but 
observably between AuNPs and magnetic beads. Because we purify the corona through a 
sucrose cushion, we are likely investigating the denser part of the corona, where the “soft 
corona” is likely removed through centrifugation.92 Protein types, however, seem to vary 
generally in relative abundance across concentrations.  
In previous studies, the limiting factor of corona formation is the NP surface, not the 
depletion of serum proteins.92 When analyzing the types of proteins that adsorb to the surface, a 
few proteins are of particular significance. First, NPs to which opsonins, which signal cells to 
ingest particles, adsorb are likely to be removed from the bloodstream within seconds by 
monocytes.94 We do see complement proteins, which are part of the innate immune adsorbing 
to the surface our our AuNPs, across models and concentrations. Ficolins, collections or 
penatraxins, which also serve as opsonins, do not constitute an important percentage of the 
coronas of our AuNPs.95   
Second, serum albumin is one of the main proteins commonly thought to form the 
corona.96 In some studies, the binding of BSA to Bare AuNPs has been observed to be 
electrostatically driven. BSA, though possessing cys-34, is not usually accessible for SH-Au 
bonds.96-97 97Further, the retention of the native epitopes of BSA,92 after adsorption to the AuNP, 
has been shown to demonstrate increased biocompatibility and solubility of the anticancer drug 
paclitaxel.98 As shown in Figure 22, serum albumin is consistently present on the models at a 
relatively high abundance. It appears to decrease in relative abundance as the concentration of 
human serum increased. We observe similar trends among the coronas of our beads, but less 
variety in relative abundance of the proteins.  
Similar results were found by Dobrovolskaia et al., in varying incubation times of pooled 
human serum with 30 nm citrate-stabilized AuNPs with various weights of PEG coating: 2, 5, 10, 
and 20 kDa.99 The most abundant proteins, according to mass spectrometry results, were 
fibrinogen and complement proteins, which are critical for plasma coagulation and immune 
	 Cheema 60 
system activating. The majority of individual proteins identified were consistent across 
incubation times or plasma donors, over functional categories: cell adhesion, complement, 
coagulation, immunoglobulins, cytoskeleton, and transport proteins. The total amount of bound 
protein however did vary between experiments. Uncoated AuNPs or ones coated with PEG with 
lower molecular weight had the highest total amount of protein detected. This, however, did not 
change the composition of the coronas they analyzed.99. Overall, the protein corona formation 
likely depends on the size, surface area and curvature of the AuNP.68  





Figure 22. Protein abundance changes in both type and quantity with concentration. Samples of AuNPs were exposed to 10% (two samples, S1 or S2) or 50% human 
serum: Bare (black), MPEG (red), and PEK (blue).  All samples were pelleted through a sucrose cushion, washed, and digested via the Sherman digestion. Samples were 
pelleted and protein supernatant was washed through a solid-phase extraction before loading onto a reverse-phase C18 column for HPLC. Mass Spectroscopy was then run at 
the Whitehead Institute Proteomics Labs. Data were run through Mascot studio and loaded onto the Scaffold Program. Heat map reflects the percent of total spectra as a relative 
protein abundance. Proteins constituting 0.1% of the corona were considered. Heat Map was created using an adapted heatmap.2 code in R.   	
	 Cheema 62 
 
Figure 23. MPEG beads have less variation in abundance and type of proteins. Samples of magnetic beads were exposed to 50% human serum: Bare, MPEG, COOH 
PEK.  All samples were pelleted through a sucrose cushion, washed, and digested via the Sherman digestion. Samples were pelleted and protein supernatant was washed 
through a solid-phase extraction before loading onto a reverse-phase C18 column for HPLC. Mass Spectroscopy was then run at the Whitehead Institute Proteomics Labs. Data 
were run through Mascot studio and loaded onto the Scaffold Program. Heat map reflects the percent of total spectra as a relative protein abundance. Proteins constituting 0.1% 
of the corona were considered. Heat Map was created using an adapted heatmap.2 code in R.   	
 In second analysis and as shown in Figure 24, we found that the relative protein 
composition of the corona seems to be dependent on molecular weight. By grouping the protein 
composition according to molecular weight, we show that heavier molecular weight proteins 
likely compose a greater percentage of the corona. The data were collected by comparing the 
molecular weight of all proteins present to their percent of total spectra.  Heavier weight proteins 
appear to constitute more of the corona. However, this could be biased by digestion techniques. 
Figure 24. Heavier molecular weight proteins constitute a greater percentage of the corona. Samples of 
magnetic beads were exposed to 50% human serum: Bare, MPEG, and PEK. All samples were pelleted through a 
sucrose cushion, washed, and digested via the Sherman digestion. Samples were pelleted and protein supernatant 
was washed through a solid-phase extraction before loaded onto a reverse-phase C18 column for HPLC. Mass 
Spectroscopy was then run at the Whitehead Institute Proteomics Labs. Data were run through Mascot studio and 
loaded onto the Scaffold Program. The percent of total spectra suggests relative protein abundance. Histogram 
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Therefore, future experiments that “spike” the sample with heavier proteins will be useful in 
understanding if truly heavier proteins constitute the corona. Previous research done by other 
groups seem to suggest that molecular weight is a factor correlating a protein’s likelihood of 
adsorb to the NP.100 However, Mirshafiee et al. found that more than 88% of proteins in the 
corona of bicyclonyne-conjugated silica NPs had a molecular weight below 30 kDa.100  
Third, while no obvious software exists to link the isoelectric points (pI) to a protein, we 
calculated the average pI of proteins adsorbed to each corona. pI data were pulled manually 
from nextprot.org by accession number. pI was then weighted to percent of total spectra, which 
was summed and normalized to 100% for relative comparison. Average pI data are particularly 
interesting given the varying surface charges in AuNPs and beads. In one study conducted by 
Casals et al., researchers conjugated 10 nm AuNPs with a negatively-charged (MUA) or 
positively-charged (AUT) surfactant layers, or stealth coating. Through mass spectrometry, they 
suggested that the protein corona can be avoided in functionalized NPs as the hard corona 
formation is not likely due to high negative charges. However, they also conversely found that 
hard corona will immediately formed and electrostatically bound on positively-charged AuNPs.92 
As shown in Table 13, the pI of proteins adsorbing to the surface of different models 
does not differ significantly despite contrasting surface charges of the various NP models (Table 
3). The electrostatics do not seem to play an important role in protein adsorption in negatively-
charged NPs. This somewhat corroborates conclusions made by Casals et al.  
Table 13. pI of individual proteins were manually pulled from nextprot.org. % of total spectra, loaded into Scaffold 
from Mascot studio, was summed for each model and normalized to 100%. pI was weighted to % of total spectra. 
Number of proteins total counted across samples was 612 (redundant) 
AuNP Model Weighted pI 
10% HS + Bare 6.2 
10% HS + Bare (S2) 6.5 
10% HS + MPEG 6.2 
10% HS + MPEG (S2) 6.3 
10% HS + PEK 6.1 
10% HS + PEK (S2) 6.1 
50% HS + MPEG 6.5 
50%HS + Bare 6.2 
50% HS + PEK 6.4 
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IV. Conclusion & Future Work 	
Conclusions: 
We successfully synthesized and functionalized 11.2 nm citrate-stabilized AuNPs with 
M-PEG and PEK polymers. In addition, we conjugated maleimide-activated magnetic beads 
with the same polymers. Our research on the interaction of our AuNP models with one-model 
proteins systems — BSA and lysozyme — demonstrated that proteins adsorb to the surface of 
the NPs and change the surface chemistry. For these results, we confirmed observations and 
quantitated changes through Dynamic Light Scattering, Zeta-Potential and UV-Visible 
Spectroscopy. Using amino acid absorbance at 260–280 nm, we could additionally acquire 
relative protein concentrations in the presence of the AuNPs. Coupling UV-Vis with 
centrifugation, we developed new protocols to quantitate how much protein adsorbs to the 
surface on the NPs, relative to [Au] concentration determined by ICP-OES. With this foundation, 
we then modified these techniques to investigate the formation of the protein corona on AuNP 
models and magnetic beads.  
 
Overall, we found that: 
1) Human serum provides a more complex environment for AuNPs, as evidenced by DLS 
and Zeta-Potential changes. Further, AuNPs are less likely to remain monodispersed in 
serum, resulting in a phase-like separation with no agitation of the AuNP-serum mix. 
2) Monitoring UV-Visible absorption at 260–280 nm is a useful technique for mass 
balancing proteins through centrifugation and the acquisition of the protein corona. 
3) “Hard” corona can be acquired through centrifugation through sucrose cushion and 
“Sherman” digestion, but leads to irreversible aggregation of particles. 
4) PEK AuNP models appear to have the most protein adsorbed on its surface. Preliminary 
calculations of the corona suggest a multi-layered corona, as well as agglutination of 
proteins, possibly through perturbing effects of centrifugation. 
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5) Protein constituents, on basis of type and relative abundance, seem to be consistent 
across models: NP or beads. Commonly found proteins include complement proteins 
and serum albumin. Protein diversity decreases with concentration. 
6) Heavier proteins seem to constitute most of the corona. 
7) Electrostatics have an unlikely or unobvious role in protein corona formation around 
negatively-charged particles. 
 
With these conclusions, we now move to conduct future research to probe our findings. The 
results of future experiments will provide deeper and valuable insight into how the protein 
corona forms around AuNPs, and what role the corona may have in the biocompatibility and 
stability of NPs within the human blood stream. 
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Future Work: 
 
Three areas to consider in adjusting the design of the NPs: 
• Why does PEK AuNPs seem to have more protein adsorbed on the surface; 
• How might a positively-charged stealth coating determine protein corona formation;92 
• Does the size of our Bare AuNPs change the constituents of protein corona? 
 
Additionally, we can also modify current experiments on our AuNP models and beads to acquire 
a better understanding of protein corona formation by: 
• Increasing incubation times of NPs with human serum to model in vivo-like conditions; 
• Investigating NPs stability under agitated conditions to model in vivo-like conditions, 
• Controlling for [AuNP] via ICP-OES, as opposed to volume, prior to incubation for less 
variable calculations in protein:NP ratios; Additionally, developing a protocol to 
determine the amount of beads in solution as to calculate the protein:bead ratios; 
• Acquiring TEM images to visualize the corona; 
• Quantifying the density of MPEG and PEK on AuNP and beads models through 
fluorescent tags; 
• Determining if similar results on the corona can be acquired using non-perturbing size-
exclusion chromatography, as a method of purification. 
 
Finally, we can also probe new directions in understanding protein corona formation: 
• Biomarkers: Does the protein corona allow for easier identification of biomarkers by 
adsorbing low abundance circulating proteins?90  
• Protein Activity: Do proteins that adsorb to the NP retain their native function?**   
																																																								
**  Dr. G. Reid Bishop, Ph.D., who is an Associate Professor of Chemistry at Belhaven University 
(rbishop@belhaven.edu, 601-968-5970), proposed this question when discussing our 2017 American 





Figure A1. Functionalization of AuNPs results in red shift in peak absorbance. 11.2 nm Bare AuNPs (black) 
were synthesized and then functionalized with 2 mg/mL MPEG (red) or 10 μM (blue, solid) or 100 μM (blue, dashed) 
of PEK overnight. Samples absorbance measured on the Cary 100 Scan UV-Visible-NIR spectrophotometer in a 1-
cm path-length cell. 10 μM shows stable AuNPs with traditionally shaped absorbance. 10 μM and 100 μM were 
selected because of stability in 50 mM KCl. 
 
A2)  
Table A2. Double Functionalization of MPEGylated AuNPs results in size and surface charge. 11.2 nm Bare 
AuNPs (black) were synthesized and then functionalized with 2 mg/mL MPEG overnight and purified with nanopure 
water. Functionalization was repeated twice. (A) Zeta-Potential measurements were taken on the Malvern Zetasizer 
with SOP parameters found in Table 1. (B) DLS measurements were taken using SOP parameters found in Table 2 
of Methods.  
(A) Model Z-Potential (mV) SD Conductivity 
MPEG (Pure) -15.5 20.2 0.1 
Double Functionalized (Pure) -28.6 15.3 0.0 
 
(B) Model Z-Average (nm) PDI PDI Width Peak 1 (d.nm) 
MPEG  (Pure) 38.6 0.3 19.9 35.9 
Double Functionalized 40.9 0.3 23.7 35.0 
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Figure A3. New sample of PEK peptide has removable impurity. A new sample of PEK peptide was ordered and 
analyzed for impurities. 100 μM of PEK was used. MS was run in Reflector mode and analyzed in FlexAnalysis.  a-
Cyano-4-hydroxycinnamic acid (CHCA) matrix and 33% Acetonitrile, 67% water, 0.1% Trifluoroacetic acid (TFA) 
solvent was used. Peptide was digested with trypsin. Calibrant Mix: 10 μM Met Enkephalin, Bradykinin, Substance P, 
P14R, Renin Substrate, ACTH 18-39, Insulin Chain A, oxidized, and Insulin Chain B, oxidized, in water. Procedure 




Figure B1. Design of magnetic beads. “(A) Schematic of the overall structure of Ocean NanoTech’s magnetic 
beads, (B) TEM images of the magnetic beads from Ocean Nanotech.” Courtesy of retailer. (Maleimide Activated 
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Magnetic Beads. Ocean NanoTech. https://www.oceannanotech.com/upload/151214124148640379e00r32.pdf 




Table C1. Exposure to BSA changes MPEGylated AuNPs’ observed surface charge. MPEGylated AuNPs were 
exposed overnight to various concentrations of BSA mg/mL with AuNP volume controlled. Samples were centrifuged 
(16,000 rcf, 18–20 minutes) and then redispersed in 0.1x PBS before measurements were taken on Malvern 
Zetasizer. SOP parameters are found in Table 2. 
Model Z-Potential (mV) SD (mV) Conductivity 
MPEG Pure –8.7 15.0 0.2 
1 mg/mL BSA –13.1 17.6 0.1 
3 mg/mL –12.3 18.3 0.2 
5 mg/mL –9.9 20.9 0.2 
10 mg/mL –22.0 12.1 0.3 
 
C2) 
Table C2. Exposure to BSA does not change PEKylated AuNPs’ observed surface charge. PEKylated AuNPs 
were exposed overnight to various concentrations of BSA mg/mL with AuNP volume controlled. Samples were 
centrifuged (16,000 rcf, 18–20 minutes) and then redispersed in 0.1x PBS before measurements were taken on 
Malvern Zetasizer. SOP parameters are found in Table 2.  
Model Z-Potential (mv) SD Conductivity 
PEK Pure –26.5 9.7 0.3 
1 mg/mL BSA –20.2 3.9 0.3 
3 mg/mL –26.0 15.6 0.3 
5 mg/mL –24.9 16.3 0.3 
10 mg/mL –25.6 13.6 0.3 
 
C3) 
Table C3. Exposure to lysozyme changes MPEGylated AuNPs’ observed surface charge. MPEGylated AuNPs 
were exposed overnight to various concentrations of lysozyme mg/mL with AuNP volume controlled. Samples were 
centrifuged (16,000 rcf, 18–20 minutes) and then redispersed in 0.1x PBS before measurements were taken on 
Malvern Zetasizer. SOP parameters are found in Table 2. 
Model Z-Potential (mV) SD Conductivity 
MPEG Pure –8.7 15.0 0.2 
0.3 mg/mL Lysozyme –1.7 12.1 0.1 
1 mg/mL –0.1 20.3 0.2 
2.5 mg/mL –4.4 40.7 0.3 
5 mg/mL 3.5 16.9 0.4 
 
C4) 
Table C4. Exposure of PEKylated AuNPs to lysozyme results in aggregation. PEKylated AuNPs were exposed 
overnight to various concentrations of lysozyme mg/mL with AuNP volume controlled. Samples were centrifuged 
(16,000 rcf, 18–20 minutes) and then redispersed in 0.1x PBS before measurements were taken on Malvern 
Zetasizer. SOP parameters are found in Table 2. 
Model Z-Potential (mV) SD Conductivity 
PEK pure –26.5 9.7 0.3 
0.3 mg/mL Lysozyme No data, sample turned purple. Filtration resulted in clear solution 
1 mg/mL No data, sample turned purple. Filtration resulted in clear solution 
2.5 mg/mL 5.5 9.5 0.3 
5 mg/mL 12.1 55.1 0.5 
 
 




Table C5. Exposure of BSA to Bare or MPEGylated AuNPs changes surface chemistry. 11.2 nm Bare AuNPs 
were synthesized, functionalized with 2 mg/mL MPEG overnight, purified with 0.1x PBS. (A) Bare and (C) MPEG 
AuNPs were exposed in constant volume to various concentrations of BSA overnight. (B) Bare and (D) MPEGylated 
AuNPs were also exposed in constant volume with 10 mg/mL BSA for various incubation periods. MPEG AuNPs 
decrease in size with increasing volumes and exposure to BSA. Measurements were taken on the Malvern Zetasizer 




































































































































































Figure C6. Modified Lowry is not a successful assay with AuNPs. Bare (black), MPEG (red), and PEK (blue) 
AuNPs were exposed to various concentrations of (A) lysozyme and (B) BSA. Standard ThermoScientific Procedure 
was followed for the microplate assay. A microplate reader was used to measure absorbance at 750 nm. Standard 
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C7)  
Table C7. BSA and lysozyme can be mass balanced. Bare, MPEG, and PEK AuNPs were exposed to various 
concentrations of lysozyme and BSA and incubated overnight. Sample was redispersed and 280 nm absorbance was 
run on the Cary50. Sample was the pelleted and separated into a supernatant and pellet. Absorbance at 280 nm 
were acquired for these samples, adjusted for dilution and summed. An absolute percent error was calculated from 






Figure D1. BSA Standard Curve from Bradford Assay. A BSA standard curve was acquired by following standard 




































Final BSA concentration (μg/mL)
Sample # of Variations Abs. Percent Error 
BSA-Bare 4 19% 
BSA-MPEG 5 9.8% 
BSA-PEK 5 13% 
Lyso-Bare 3 15% 
Lyso-MPEG 8 10% 
Lyso-PEK 8 10% 






Figure D2. [Au] Standard Curve from ICP-OES. A [Au] standard curve was acquired through a serial dilution of 
KAuCl4 in 2% nitric acid. All measurements were taken by the Optima 7000 DV following ICP-OES protocols. 








Figure E1. KI/I2 can be used to confirm MPEG presence. Samples were exposed 1:1 to 1:4:40 I2:KI:H2O and then 
diluted 1:30 in nanopure water. AuNPs had additionally been diluted 1:3 before exposure. Absorbance readings were 
measured by the Cary100. Inset images shows observable aggregation of MPEG. Absorbance around 280 nm is 
erratic and prevents quantification of protein concentration via normal Amino Acid Absorbance.61 
 




























































Figure E2.: 2% CHAPS and 8 M Urea does not contribute to spectroscopy: UV–Visible Spectroscopy was used 
to measure the absorbance of Human Serum (purple) at 280 nm on Cary100. 5% Samples were prepared with equal 
concentrations of Bare (black), MPEG (red), and PEK (blue) AuNPs and then incubated with 2% CHAPS and 8 M 
Urea (“D”). Measurements were taken before and after exposure to the denaturant, *Though the dotted lines labels 




Figure E3: 2% CHAPS and 8 M Urea does not adversely effect mass balance: UV–Visible Spectroscopy was 
used to measure the absorbance of Human Serum (purple) at 280 nm on Cary100. 5% Samples were prepared with 
equal concentrations of Bare (black), MPEG (red), and PEK (blue) AuNPs and then incubated with 2% CHAPS and 8 
M Urea (“D”). Measurements were taken before spin down. The pellet and supernatant’s UV–Vis was acquired 
separately and then summed (S). The percent error was calculated, and shown below: 
Operation     %Difference 
5% HS + Bare + D    15% 
5% HS + MPEG +D    –1.5% 


















5% HS + Bare Bare + D
5% HS +MPEG MPEG + D
5% HS +PEK  PEK + D

















5% HS + Bare + D
(S) 5% +Bare + D
5% HS +MPEG 
(S) 5% +MPEG + D
5% HS +PEK  
(S) 5% +PEK + D
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E4)  
Table E4. Proteins can be mass balanced during acquisition of the protein corona. Samples of 
Bare, MPEG, and PEKylated AuNPs were incubated with 10% Human Serum and then spun through a 
sucrose cushion at 18 xg. Pellets were washed three times with 0.1x PBS and then redispersed. At the 
step, absorbance at 280 and 260 nm were acquired on the NanoDrop 2000. Relative protein 
concentration was calculated by diving A260/A280 and corrected to a 2 mg/mL BSA standard. Percent 
differences compare the sum of pellets and washes to the protein concentration measured in the original 
sample. MPEGylated AuNPs are less efficient at spinning down than Bare or PEKylated AuNPs. 







adjustment % DIFF 
2 mg/mL BSA 1.023 N/A *2 -49% 
20%HS 13.376 X x 
 10% HS 6.138 X *2 -8.2% 
Bare AuNP 0.036 Diluted 1/2 *1/2 
 
10% HS + Bare 6.997 
4 mL sample 
(1:1)   
 
Bare Sucrose Cushion - Supernatant 2.013 
4 mL sucrose + 
2 mL sample *1 
 Bare Sucrose Cusion - Pellet 2.181 2 mL sample x 
 Bare Wash 1 - Sup 3.417 7 mL *1/2 
 Bare Wash 2 - Sup 0.686 7 mL *1/2 
 Bare Final Wash - xSup 0.11 7 mL *1 SUM 
Bare Final Pellet 0.342 1 mL - (100 uL) *4 6.4 
Bare Final Pellet - Sup 0.233 <1 mL *4 % DIFF 
Bare Digested 0.418 1.2 mL x -8.3% 
MPEG AuNP 0.032 Diluted 1/2 
  
10% HS + MPEG 7.272 
4 mL sample 
(1:1)   
 
MPEG Sucrose Cushion - Supernatant 2.124 
4 mL sucrose + 
2 mL sample *1 
 MPEG Sucrose Cushion - Pellet 3.377 2 mL sample x 
 MPEG Wash 1 - Sup 3.786 7 mL *1/2 
 MPEG Wash 2 - Sup 0.639 7 mL *1/2 
 MPEG Final Wash - Sup 0.065 7 mL *1 SUM 
MPEG Final Pellet 0.24 1 mL - (100 uL) *4 5.8 
MPEG Final Pellet - Sup 0.111 <1 mL *4 % DIFF 
MPEG Digested - Sup 0.521 1.2 mL x -21% 
PEK AuNP 0.219 Diluted 1/2 
  
10%HS + PEK 6.884 
4 mL sample 
(1:1)   
 
PEK Sucrose Cushion - Supernatant 2.606 
4 mL sucrose + 
2 mL sample *1 
 PEK Sucrose Cushion - Pellet 2.876 2 mL sample x 
 PEK Wash 1 - Sup 3.789 7 mL *1/2 
 PEK Wash 2 - Sup 0.754 7 mL *1/2 
 PEK Final Wash - Sup 0.055 7 mL *1 SUM 
PEK Final Pellet 0.212 1 mL - (100 uL) *4 6.0 
PEK Final Pellet - Sup 0.067 <1 mL *4 % DIFF 
PEK Digested - Sup 0.51 1.2 mL x -13% 
 
	 Cheema 77 
 
E5) 
Table E5. Constants used in calculations by Equations 1, 2, and 3. White boxes show 
variables. 
AuNPs Parameters Values Units 
  MM of Au 196.967 g/mol 1.00E+07 nm/cm 
NA 6.02E+23 1/mol 
  Density 19.30 g/cm3 
  Size (diameter) Experimental nm 
  Surface area  1.97E+02 nm3 1.97E-12 cm2 
Volume 7.36E+02 nm3 7.36E-19 cm3 
Mass/part 1.42E-17 g 
  Atoms/part 4.34E+04 
   [NP] at synthesis  1.39E+13 NP/mL 
  Surface area/mL 2.73E+01 cm^2/mL 
  Volume/mL 1.02E-05 cm^3/mL 
  ICP conc. Experimental ppm 0.001 mg/mL 
Conc.  5.08E-06 Molar (moles/L) 
  [NP] at synthesis  7.04E+10 NP/mL 
  Surface area/mL 1.39E-01 cm2/mL 
  Volume/mL 5.18E-08 cm3/mL 
  Protein Parameters 
    Density  1.35 g/cm3 
  Conc. (NanoDrop) Experimental mg/mL 
  Volume/mL 1.78E-04 cm3/mL soln  
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Table F1.  Some proteins are only found on certain AuNP models exposed to 10% Human Serum. Samples of AuNPs were exposed to 10% 
human serum: Bare (black), MPEG (red), and PEK (blue). All samples were pelleted through a sucrose cushion, washed, and digested via the Sherman 
digestion. Protein supernatant was washed through a solid-phase extraction before loaded onto a reverse-phase C18 column for HPLC. Mass 
Spectroscopy was then run at the Whitehead Institute Proteomics Labs. Data were run through Mascot and PEAKS studio and loaded onto the Scaffold 
Program (Protein threshold=99%, min. peptides=2, and peptide threshold=95%). Table shows proteins SPECIFICALLY found on AuNP model. For 
example, proteins found across all AuNP models of the same sample (i.e., common core) or found within 2 models of the same sample are not listed. 
AuNP Model Bare only MPEG only PEK only 
10% HS Sample 1 2 1 2 1 2 
Proteins Found apolipoprotein C-I 
precursor   
alpha-1-acid 
glycoprotein 1 
precursor   
coagulation factor 
XI preproprotein   
apolipoprotein C-III precursor   alpha-1-
antichymotrypsin 
precursor   
hemoglobin subunit delta   
 complement factor D 
isoform 1 preproprotein   
coagulation factor VII 
isoform a preproprotein   
complement 
component C9 
preproprotein   
apolipoprotein M isoform 2   complement 
component C6 
precursor   
mannan-binding lectin 
serine protease 2 isoform 1 
preproprotein   
 complement factor H-
related protein 3 isoform 
2 precursor   
collagen alpha-1(I) 




isoform 1   
ceruloplasmin precursor   ficolin-2 isoform a 
precursor   
resistin precursor   
 histone H2B type 1-D   dermcidin isoform 2 
preproprotein   
protein AMBP 
preproprotein   
cholesteryl ester transfer protein 
isoform 2 precursor   
ficolin-3 isoform 1 
precursor   
solute carrier family 2, 
facilitated glucose 
transporter member 14 
isoform a   
 insulin-like growth 
factor-binding protein 5 
precursor   
fibrinogen gamma 
chain isoform gamma-A 
precursor   
pyruvate kinase 
PKM isoform c   
coagulation factor XI preproprotein   hemoglobin subunit 
alpha   
tubulin alpha-1A chain 
isoform 1   
 PREDICTED: 
complement C5 isoform 
X1   
hepatocyte growth 
factor activator isoform 
1 preproprotein   
  cofilin-1   hemoglobin subunit 
beta   
WD repeat-containing 
protein 1 isoform 1   
 selenoprotein P isoform 
1 precursor   
platelet factor 4 variant 
precursor   
  complement C2 isoform 1 
preproprotein   
integrin-linked protein 
kinase isoform 1   
  
   serum amyloid P-
component precursor   
  complement component C8 alpha 
chain preproprotein   
PREDICTED: CD5 
antigen-like isoform X1   
  
   vitamin K-dependent 
protein C preproprotein   
  complement component C8 beta 
chain isoform 1 preproprotein   
PREDICTED: fermitin 
family homolog 3 
isoform X2   
  
       complement component C8 gamma 
chain precursor   
PREDICTED: 
mannan-binding lectin 
serine protease 1 
isoform X3   
  
       complement factor H-related protein 
2 isoform 1 precursor   
    
       integrin-linked protein kinase 
isoform 1   
    
       kininogen-1 isoform 1 precursor       
       myeloperoxidase precursor       
       plasma kallikrein isoform 1 
preproprotein   
    
       selenoprotein P isoform 1 precursor       
       serum paraoxonase/arylesterase 1 
precursor   
    
       thrombospondin-4 isoform b       
       tubulin beta chain isoform d       
F1) 
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Table F2.  Some proteins are only found on AuNP models exposed to 50% Human Serum. Samples of AuNPs were exposed to 50% human serum: Bare 
(black), MPEG (red), and PEK (blue). All samples were pelleted through a sucrose cushion, washed, and digested via the Sherman digestion. Samples were 
pelleted and protein supernatant was washed through a solid-phase extraction before loaded onto a reverse-phase C18 column for HPLC. Mass Spectroscopy 
was then run at the Whitehead Institute Proteomics Labs. Data were run through Mascot and PEAKS studio and loaded onto the Scaffold Program (Protein 
threshold=99%, min. peptides=2, and peptide threshold=95%). Table shows proteins SPECIFICALLY found on NP model. For example, proteins found across all 
AuNP models of the same sample (i.e., common core) or found within 2 models of the same sample are not listed. 
Surface Coating Bare only  MPEG only PEK only  
Proteins Found apolipoprotein E isoform b 
precursor   integrin beta-1 isoform 1D precursor   
 
alpha-1-antitrypsin precursor     
 
coagulation factor XI 
preproprotein   
bactericidal permeability-increasing 
protein precursor   
 
complement component C9 preproprotein   
 
 collagen alpha-1(I) chain 
preproprotein   
   
glyceraldehyde-3-phosphate dehydrogenase isoform 1   
 
 complement factor H-
related protein 3 isoform 2 
precursor   
   
polymeric immunoglobulin receptor precursor   
 
 haptoglobin isoform 1 
preproprotein   
   mannan-binding lectin serine protease 2 isoform 1 
preproprotein   
 
 hemopexin precursor      beta-actin-like protein 2    
 inter-alpha-trypsin 
inhibitor heavy chain H4 
isoform 2 precursor   
   
PREDICTED: immunoglobulin lambda-like polypeptide 1-
like isoform X1 [Capra hircus] 
 
 kininogen-1 isoform 1 
precursor   
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Figure F3. Protein abundance changes in both type and quantity with concentration. Samples of AuNPs were exposed to 10% (two samples, S1 or S2) or 
50% human serum: Bare (black), MPEG (red), and PEK (blue).  All samples were pelleted through a sucrose cushion, washed, and digested via the Sherman 
digestion. Samples were pelleted and protein supernatant was washed through a solid-phase extraction before loading onto a reverse-phase C18 column for 
HPLC. Mass Spectroscopy was then run at the Whitehead Institute Proteomics Lab. Data were run through PEAKS studio and loaded onto the Scaffold Program. 
Heat map reflects the percent of total spectra as a relative protein abundance. Proteins constituting 1% of greater of the corona were considered. Heat Map was 
created using an adapted heatmap.2 code in R.   
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Figure F4. Protein abundance changes in both type and quantity with concentration. Samples of magnetic beads were exposed to 50% human serum: Bare, 
MPEG, PEK, and COOH.  All samples were pelleted through a sucrose cushion, washed, and digested via the Sherman digestion. Samples were pelleted and 
protein supernatant was washed through a solid-phase extraction before loaded onto a reverse-phase C18 column for HPLC. Mass Spectroscopy was then run at 
the Whitehead Institute Proteomics Lab. Data were run through PEAKS studio and loaded onto the Scaffold Program. Heat map reflects the percent of total 
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